Legacy Lifepoint Health 10-Q 25 Jul 14 2014 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Jun. 30, 2014	Jul. 18, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Jun-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Entity Registrant Name	'LIFEPOINT HOSPITALS, INC.	'
Entity Central Index Key	'0001301611	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	45,141,488
Trading Symbol	'LPNT	'

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Consolidated Statements Of Operations [Abstract]	'	'	'	'
Revenues before provision for doubtful accounts	$1,246.20	$1,075.70	$2,429	$2,175.90
Provision for doubtful accounts	199.2	180.8	374.8	349.9
Revenues	1,047	894.9	2,054.20	1,826
Salaries and benefits	488.5	422.1	963.3	855.3
Supplies	162.5	144.1	319.5	288.8
Other operating expenses	258.3	222.9	501.8	444.4
Other income	-21	-11	-34.9	-16.7
Depreciation and amortization	60.9	55.9	122	111.7
Interest expense, net	31.3	22.6	65.2	46.5
Gain on settlement of pre-acquisition contingent obligation	'	-5.6	'	-5.6
Debt transaction costs	'	'	'	4.4
Operating expenses, total	980.5	851	1,936.90	1,728.80
Income from continuing operations before income taxes	66.5	43.9	117.3	97.2
Provision for income taxes	24.7	16.7	37.8	37
Income from continuing operations	41.8	27.2	79.5	60.2
Income from discontinued operations, net of income taxes	'	0.3	'	0.4
Net income	41.8	27.5	79.5	60.6
Less: Net income attributable to noncontrolling interests	-2.7	-0.1	-3.3	-0.8
Net income attributable to LifePoint Hospitals, Inc.	39.1	27.4	76.2	59.8
Basic earnings per share attributable to LifePoint Hospitals, Inc. stockholders:	'	'	'	'
Continuing operations	$0.88	$0.58	$1.69	$1.29
Discontinued operations	'	$0.01	'	$0.01
Net income	$0.88	$0.59	$1.69	$1.30
Diluted earnings per share attributable to LifePoint Hospitals, Inc. stockholders:	'	'	'	'
Continuing operations	$0.84	$0.57	$1.61	$1.25
Discontinued operations	'	'	'	$0.01
Net income	$0.84	$0.57	$1.61	$1.26
Weighted average shares and dilutive securities outstanding:	'	'	'	'
Basic	44.5	46.5	45.2	46.2
Diluted	46.5	47.7	47.3	47.5
Amounts attributable to LifePoint Hospitals, Inc. stockholders:	'	'	'	'
Income from continuing operations, net of income taxes	39.1	27.1	76.2	59.4
Income from discontinued operations, net of income taxes	'	0.3	'	0.4
Net income	$39.10	$27.40	$76.20	$59.80

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$342	$637.90
Accounts receivable, less allowances for doubtful accounts of $763.9 and $741.2 at June 30, 2014 and December 31, 2013, respectively	646.4	595.7
Inventories	106.9	102
Prepaid expenses	38.7	38
Deferred tax assets	130.1	147.7
Other current assets	106.5	72.9
Total current assets	1,370.60	1,594.20
Property and equipment:	'	'
Land	129.4	112.3
Buildings and improvements	2,065.70	2,019.60
Equipment	1,525.80	1,469.90
Construction in progress (estimated cost to complete and equip after June 30, 2014 is $72.8)	60.1	58.7
Property and equipment, gross	3,781	3,660.50
Accumulated depreciation	-1,563.60	-1,463.30
Property and equipment, net	2,217.40	2,197.20
Deferred loan costs, net	33.5	31.1
Intangible assets, net	71.4	72.6
Other	38.5	40.7
Goodwill	1,630.10	1,651
Total assets	5,361.50	5,586.80
LIABILITIES AND EQUITY	'	'
Accounts payable	148.1	135.9
Accrued salaries	146.6	139.6
Other current liabilities	185.4	197.2
Current maturities of long-term debt	12.9	583
Total current liabilities	493	1,055.70
Long-term debt	2,202.50	1,793.80
Deferred income tax liabilities	203.8	233.1
Long-term portion of reserves for self-insurance claims	133.9	139.8
Other long-term liabilities	56.3	55.4
Long-term income tax liability	18.9	16.6
Total liabilities	3,108.40	3,294.40
Redeemable noncontrolling interests	84.7	59.8
Equity:	'	'
Common stock, $0.01 par value; 90,000,000 shares authorized; 66,061,293 and 65,548,140 shares issued at June 30, 2014 and December 31, 2013, respectively	0.7	0.7
Capital in excess of par value	1,481.60	1,470.70
Accumulated other comprehensive income	3.4	3.4
Retained earnings	1,423.20	1,347
Common stock in treasury, at cost, 20,930,105 and 18,404,586 shares at June 30, 2014 and December 31, 2013, respectively	-760.6	-611.7
Total LifePoint Hospitals, Inc. stockholders' equity	2,148.30	2,210.10
Noncontrolling interests	20.1	22.5
Total equity	2,168.40	2,232.60
Total liabilities and equity	$5,361.50	$5,586.80

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, except Share data, unless otherwise specified
Consolidated Balance Sheets [Abstract]	'	'
Accounts receivable, allowances for doubtful accounts	$763.90	$741.20
Estimated cost to complete and equip	$72.80	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares issued	66,061,293	65,548,140
Common stock in treasury, shares	20,930,105	18,404,586

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'	'	'
Net income	$41.80	$27.50	$79.50	$60.60
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'	'
Income from discontinued operations, net of income taxes	'	-0.3	'	-0.4
Stock-based compensation	6.4	6.3	13.1	13.1
Depreciation and amortization	60.9	55.9	122	111.7
Amortization of physician minimum revenue guarantees	3.8	4.5	7.7	9
Amortization of debt discounts, premium and deferred loan costs	4.3	6	11.6	13.1
Gain on settlement of pre-acquisition contingent obligation	'	-5.6	'	-5.6
Debt transaction costs	'	'	'	4.4
Deferred income taxes (benefit)	36.5	-36.6	-5.1	-43.7
Reserve for self-insurance claims, net of payments	-1.4	2.1	4.7	6.7
Increase (decrease) in cash from operating assets and liabilities, net of effects from acquisitions and divestitures:	'	'	'	'
Accounts receivable	22.2	10.9	-28.3	-18.6
Inventories and other current assets	-2.7	10.9	20.4	4.8
Accounts payable and accrued expenses	-31.3	-15.8	-31.6	-26
Income taxes payable /receivable	-71.8	-7.5	-19.3	19.5
Other	-0.7	-0.8	1.9	0.7
Net cash provided by operating activities-continuing operations	68	57.5	176.6	149.3
Net cash used in operating activities-discontinued operations	'	-0.6	'	-0.2
Net cash provided by operating activities	68	56.9	176.6	149.1
Cash flows from investing activities:	'	'	'	'
Purchases of property and equipment	-31.2	-37.3	-53.7	-75.8
Acquisitions, net of cash acquired	-27.2	-4.9	-87.8	-6.2
Other	0.1	1.2	-0.4	1.4
Net cash used in investing activities	-58.3	-41	-141.9	-80.6
Cash flows from financing activities:	'	'	'	'
Proceeds from borrowings	412	'	412	323
Payments of borrowings	-579.8	-3.6	-579.8	-317.2
Repurchases of common stock	-36.1	-0.1	-171.9	-7.2
Payment of debt financing costs	-5.5	-0.1	-5.9	-1
Proceeds from exercise of stock options	11.1	4.6	18.3	28.2
Other	-1.7	-2.1	-3.3	-4.3
Net cash (used in) provided by financing activities	-200	-1.3	-330.6	21.5
Change in cash and cash equivalents	-190.3	14.6	-295.9	90
Cash and cash equivalents at beginning of period	532.3	160.4	637.9	85
Cash and cash equivalents at end of period	342	175	342	175
Supplemental disclosure of cash flow information:	'	'	'	'
Interest payments	56.9	28.2	60.6	35.4
Capitalized interest	0.1	0.3	0.3	0.7
Income tax payments, net	$60	$60.90	$62.30	$61.40

Consolidated_Statements_Of_Sto

Consolidated Statements Of Stockholders' Equity (USD $)	Common Stock [Member]	Capital In Excess Of Par Value [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Noncontrolling Interests [Member]	Total
In Millions, except Share data
Balance at Dec. 31, 2013	$0.70	$1,470.70	$3.40	$1,347	($611.70)	$22.50	$2,232.60
Balance, shares at Dec. 31, 2013	47,100,000	'	'	'	'	'	'
Net income	'	'	'	76.2	'	0.5	76.7
Exercise of stock options and tax benefits of stock-based awards	'	22.5	'	'	'	'	22.5
Exercise of stock options and tax benefits of stock-based awards, shares	500,000	'	'	'	'	'	'
Stock-based compensation	'	13.1	'	'	'	'	13.1
Conversion of 3 1/2 % Notes	'	-22.1	'	'	23	'	0.9
Conversion of 3 1/2 % Notes, shares	600,000	'	'	'	'	'	600,000
Repurchases of common stock, at cost	'	'	'	'	-171.9	'	-171.9
Repurchases of common stock, at cost, shares	-3,100,000	'	'	'	'	'	'
Noncash change in noncontrolling interests as a result of acquisition and other	'	-2.6	'	'	'	-1.9	-4.5
Cash distributions to noncontrolling interests	'	'	'	'	'	-1	-1
Balance at Jun. 30, 2014	$0.70	$1,481.60	$3.40	$1,423.20	($760.60)	$20.10	$2,168.40
Balance, shares at Jun. 30, 2014	45,100,000	'	'	'	'	'	'

Organization_Basis_Of_Presenta

Organization, Basis Of Presentation And Recently Issued Accounting Pronouncement	6 Months Ended
	Jun. 30, 2014
Organization, Basis Of Presentation And Recently Issued Accounting Pronouncement [Abstract]	'
Organization And Basis Of Presentation	'
	Note 1. Organization, Basis of Presentation and Recently Issued Accounting Pronouncements
	Organization
	LifePoint Hospitals, Inc., a Delaware corporation, acting through its subsidiaries, operates general acute care hospitals primarily in non-urban communities in the United States (“U.S.”). Unless the context otherwise indicates, LifePoint Hospitals, Inc. and its subsidiaries are referred to herein as the “Company.” At June 30, 2014, on a consolidated basis, the Company operated 62 hospital campuses in 20 states. Unless noted otherwise, discussions in these notes pertain to the Company’s continuing operations, which exclude the results of those facilities that have previously been disposed.
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, and disclosures considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
	Recently Issued Accounting Pronouncements
	ASU No. 2014-9, “Revenue from Contracts with Customers”
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-9, “Revenue from Contracts with Customers” (“ASU 2014-9”).  ASU 2014-9 provides for a single comprehensive principles-based standard for the recognition of revenue across all industries through the application of the following five-step process:
	Step 1: Identify the contract(s) with a customer.
	Step 2: Identify the performance obligations in the contract.
	Step 3: Determine the transaction price.
	Step 4: Allocate the transaction price to the performance obligations in the contract.
	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
	Among other provisions and in addition to expanded disclosure about the nature, amount, timing and uncertainty of revenue, as well as certain additional quantitative and qualitative disclosures, ASU 2014-9 changes the healthcare industry specific presentation guidance under ASU 2011-7, “Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities” (“ASU 2011-7”).  The provisions of ASU 2014-9 are effective for annual periods beginning after December 15, 2016, including interim periods within those years.  Early adoption is not permitted.
	ASU No. 2014-8, “Presentation of Financial Statements and Property, Plant, and Equipment - Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity”
	In April 2014, the FASB issued ASU No. 2014-8, “Presentation of Financial Statements and Property, Plant, and Equipment - Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity” (“ASU 2014-8”).  Among other provisions and in addition to expanded disclosures, ASU 2014-8 changes the definition of what components of an entity qualify for discontinued operations treatment and reporting from a reportable segment, operating segment, reporting unit, subsidiary or asset group to only those components of an entity that represent a strategic shift that has, or will have, a major effect on an entity’s operations and financial results.  Additionally, ASU 2014-8 requires disclosure about a disposal of an individually significant component of an entity that does not qualify for discontinued operations presentation in the financial statements, including the pretax profit or loss, attributable to the component of an entity for the period in which it is disposed of or is classified as held for sale.  The disclosure of this information is required for all of the same periods that are presented in the entity’s results of operations for the period.  The provisions of ASU 2014-8 are effective prospectively for all disposals or classifications as held for sale of components of an entity that occur within annual periods beginning on or after December 15, 2014, and interim periods within those years.  Early adoption is permitted.
	The Company may, from time-to-time, identify one or more individual facilities that do not meet the Company’s on-going or future business strategy.  In accordance with ASU 2014-8, in the event that an individually significant facility is identified for disposal but does not represent a strategic shift that has, or will have, a major effect on the Company’s operations and financial results, the results of the identified facility would continue to be reported as a component of the Company’s consolidated results.  However, in this event and in accordance with ASU 2014-8, additional disclosures would be required.

Revenue_Recognition_And_Accoun

Revenue Recognition And Accounts Receivable	6 Months Ended
	Jun. 30, 2014
Revenue Recognition And Accounts Receivable [Abstract]	'
Revenue Recognition And Accounts Receivable	'
	Note 2. Revenue Recognition and Accounts Receivable
	The Company recognizes revenues in the period in which services are performed. Accounts receivable primarily consist of amounts due from third-party payors and patients. The Company’s ability to collect outstanding receivables is critical to its results of operations and cash flows.  Amounts the Company receives for treatment of patients covered by governmental programs such as Medicare and Medicaid and other third-party payors such as health maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”) and other private insurers are generally less than the Company’s established billing rates.  Additionally, to provide for accounts receivable that could become uncollectible in the future, the Company establishes an allowance for doubtful accounts to reduce the carrying value of such receivables to their estimated net realizable value.  Accordingly, the revenues and accounts receivable reported in the Company’s accompanying unaudited condensed consolidated financial statements are recorded at the net amount expected to be received.
	The Company’s revenues before provision for doubtful accounts by payor and approximate percentages of revenues were as follows for the three and six months ended June 30, 2014 and 2013 (in millions):
		Three Months Ended June 30,								Six Months Ended June 30,
		2014				2013				2014				2013
				% of				% of				% of				% of
		Amount		Revenues		Amount		Revenues		Amount		Revenues		Amount		Revenues
	Medicare	$	325.0	31.0	%	$	289.4	32.3	%	$	641.8	31.2	%	$	607.6	33.3	%
	Medicaid		149.8	14.3			124.4	13.9			290.0	14.1			251.2	13.8
	HMOs, PPOs and other private insurers		577.6	55.1			466.6	52.2			1,114.2	54.3			924.2	50.6
	Self-pay		172.3	16.5			176.5	19.7			339.5	16.5			357.9	19.6
	Other		21.5	2.1			18.8	2.1			43.5	2.1			35.0	1.9
	Revenues before provision for
	doubtful accounts		1,246.2	119.0			1,075.7	120.2			2,429.0	118.2			2,175.9	119.2
	Provision for doubtful accounts		-199.2	-19			-180.8	-20.2			-374.8	-18.2			-349.9	-19.2
	Revenues	$	1,047.0	100.0	%	$	894.9	100.0	%	$	2,054.2	100.0	%	$	1,826.0	100.0	%
	The primary uncertainty of the Company’s accounts receivable lies with uninsured patient receivables and deductibles, co-payments or other amounts due from individual patients.  The Company has an established process to determine the adequacy of the allowance for doubtful accounts that relies on a number of analytical tools and benchmarks to arrive at a reasonable allowance. No single statistic or measurement determines the adequacy of the allowance for doubtful accounts. Some of the analytical tools that the Company utilizes include, but are not limited to, historical cash collection experience, revenue trends by payor classification and revenue days in accounts receivable.  Accounts receivable are written off after collection efforts have been followed in accordance with the Company’s policies.
	The following is a summary of the Company’s activity in the allowance for doubtful accounts for the six months ended June 30, 2014 (in millions):
	Balance at January 1, 2014	$	741.2
	Additions recognized as a reduction to revenues		374.8
	Accounts written off, net of recoveries		-352.1
	Balance at June 30, 2014	$	763.9
	The allowances for doubtful accounts as a percent of gross accounts receivable, net of contractual discounts were 54.2% and 55.4% as of June 30, 2014 and December 31, 2013, respectively.  Additionally, as of June 30, 2014 and December 31, 2013, the allowances for doubtful accounts plus certain contractual allowances and discounts related to self-pay patients as a percentage of self-pay receivables were 87.8% and 86.5%, respectively.

General_And_Administrative_Cos

General And Administrative Costs	6 Months Ended
	Jun. 30, 2014
General And Administrative Costs [Abstract]	'
General And Administrative Costs	'
	Note 3. General and Administrative Costs
	The majority of the Company’s expenses are “cost of revenue” items. Costs that could be classified as “general and administrative” by the Company would include its hospital support center overhead costs, which were $53.9 million and $43.0 million for the three months ended June 30, 2014 and 2013, respectively, and $106.1 million and $91.0 million for the six months ended June 30, 2014 and 2013, respectively.  Included in the Company’s hospital support center overhead costs are depreciation and amortization expense related to the Company’s information systems platforms as well as transactional expenses related to the Company’s recent acquisitions, including legal and consulting fees.

Fair_Value_Of_Financial_Instru

Fair Value Of Financial Instruments	6 Months Ended
	Jun. 30, 2014
Fair Value Of Financial Instruments [Abstract]	'
Fair Value Of Financial Instruments	'
	Note 4. Fair Value of Financial Instruments
	In accordance with Accounting Standards Codification (“ASC”) 825-10, “Financial Instruments” and ASC 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), the fair value of the Company’s financial instruments are further described as follows.
	Cash and Cash Equivalents, Accounts Receivable and Accounts Payable
	The carrying amounts reported in the accompanying unaudited condensed consolidated balance sheets for cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short-term maturity of these instruments.
	Long-Term Debt
	The carrying amounts and fair values of the Company’s senior secured term loan facility (the “Term Facility”) and senior secured incremental term loans (the “Incremental Term Loans”) under its senior secured credit agreement with, among others, Citibank, N.A. as administrative agent, and the lenders party thereto (the “Senior Credit Agreement”), 6.625%  unsecured senior notes due October 1, 2020 (the “6.625% Senior Notes”), 5.5% unsecured senior notes due December 1, 2021 (the “5.5% Senior Notes”) and 3½% convertible senior subordinated notes due May 15, 2014 (the “3½% Notes”) as of June 30, 2014 and December 31, 2013 were as follows (in millions):
		Carrying Amount				Fair Value
		June 30,		December 31,		June 30,		December 31,
		2014		2013		2014		2013
	Senior Credit Agreement:
	Term Facility	$	427.5	$	433.1	$	427.0	$	434.2
	Incremental Term Loans, excluding unamortized discount	$	222.6	$	222.6	$	222.8	$	224.2
	6.625% Senior Notes	$	400.0	$	400.0	$	431.0	$	425.0
	5.5% Senior Notes, excluding unamortized premium	$	1,100.0	$	700.0	$	1,153.6	$	703.5
	3 ½ %  Notes, excluding unamortized discount	$	-	$	575.0	$	-	$	622.4
	The fair values of the Term Facility, the Incremental Term Loans, the 6.625% Senior Notes and the 5.5% Senior Notes were estimated based on the average bid and ask price as determined using published rates and categorized as Level 2 within the fair value hierarchy in accordance with ASC 820-10.  The fair values of the 3½% Notes were estimated based on the quoted market prices determined using the closing share price of the Company’s common stock and categorized as Level 1 within the fair value hierarchy in accordance with ASC 820-10. As more fully discussed in Note 7, effective May 12, 2014, the Company issued $400.0 million of additional 5.5% Senior Notes at a premium of $12.0 million for total net proceeds from the issuance of $412.0 million. The net proceeds from this additional issuance were used to fund, in part, the cash-settled portion of the maturity or conversion of the 3½% Notes on or before May 15, 2014.

Acquisitions

Acquisitions	6 Months Ended
	Jun. 30, 2014
Acquisitions [Abstract]	'
Acquisitions	'
	Note 5. Acquisitions
	Rutherford Regional Medical Center (“Rutherford”)
	Effective June 1, 2014,  Duke LifePoint Healthcare,  a joint venture between the Company and a wholly-controlled affiliate of Duke University Health System, Inc., acquired an 80% interest in Rutherford, a 143 bed acute care hospital located in Rutherfordton,  North Carolina for approximately $27.2 million, including net working capital. The Company indirectly owns a controlling interest in Duke LifePoint Healthcare. The Company has committed to invest in Rutherford an additional $60.0 million in capital expenditures and improvements over the next ten years.  The results of operations of Rutherford are included in the Company’s results of operations beginning on June 1, 2014. The fair values assigned to certain assets acquired and liabilities assumed in relation to the Company’s acquisition of Rutherford have been prepared on a preliminary basis and are subject to change. Specifically, the Company is further assessing the valuation of certain tangible and intangible assets acquired and obligations assumed. The Company expects to finalize its analysis during 2014.
	Wilson Medical Center (“Wilson”)
	Effective March 1, 2014, Duke LifePoint Healthcare acquired an 80% interest in an entity that owns Wilson, a 294 bed hospital and 90 bed long-term care facility located in Wilson, North Carolina for approximately $59.8 million, including net working capital. The Company has committed to invest in Wilson an additional $120.0 million in capital expenditures and improvements over the next ten years.  The results of operations of Wilson are included in the Company’s results of operations beginning on March 1, 2014. The fair values assigned to certain assets acquired and liabilities assumed in relation to the Company’s acquisition of Wilson have been prepared on a preliminary basis and are subject to change. Specifically, the Company is further assessing the valuation of the property and equipment, acquired intangible assets and certain other assets acquired and obligations assumed. The Company expects to finalize its analysis during 2014.

Goodwill_And_Intangible_Assets

Goodwill And Intangible Assets	6 Months Ended
	Jun. 30, 2014
Goodwill And Intangible Assets [Abstract]	'
Goodwill And Intangible Assets	'
	Note 6. Goodwill and Intangible Assets
	Goodwill
	The Company accounts for its acquisitions in accordance with ASC 805-10, “Business Combinations” using the acquisition method of accounting. Goodwill represents the excess of the cost of an acquired entity over the net amounts assigned to assets acquired and liabilities assumed. In accordance with ASC 350-10, “Intangibles — Goodwill and Other” goodwill and intangible assets with indefinite lives are reviewed by the Company at least annually for impairment. The Company’s business comprises a single reporting unit for impairment test purposes. For the purposes of these analyses, the Company’s estimates of fair value are based on a combination of the income approach, which estimates the fair value of the Company based on its future discounted cash flows, and the market approach, which estimates the fair value of the Company based on comparable market prices. The Company performed its most recent annual impairment test as of October 1, 2013 and did not incur an impairment charge.
	Intangible Assets
	Summary of Intangible Assets
	The following table provides information regarding the Company’s intangible assets, which are included in the accompanying unaudited condensed consolidated balance sheets at June 30, 2014 and December 31, 2013 (in millions):
		June 30,		December 31,
		2014		2013
	Amortized intangible assets:
	Contract-based physician minimum revenue guarantees
	Gross carrying amount	$	67.8	$	73.4
	Accumulated amortization		-37.3		-39.4
	Net total		30.5		34.0
	Non-competition agreements
	Gross carrying amount		24.5		24.5
	Accumulated amortization		-15.6		-14.1
	Net total		8.9		10.4
	Total amortized intangible assets
	Gross carrying amount		92.3		97.9
	Accumulated amortization		-52.9		-53.5
	Net total		39.4		44.4
	Indefinite-lived intangible assets:
	Certificates of need and certificates of need exemptions		27.9		24.9
	Licenses, provider numbers, accreditations and other		4.1		3.3
	Net total		32.0		28.2
	Total intangible assets:
	Gross carrying amount		124.3		126.1
	Accumulated amortization		-52.9		-53.5
	Net total	$	71.4	$	72.6
	Contract-Based Physician Minimum Revenue Guarantees
	The Company has committed to provide certain financial assistance pursuant to recruiting agreements, or “physician minimum revenue guarantees,” with various physicians practicing in the communities it serves. In consideration for a physician relocating to one of its communities and agreeing to engage in private practice for the benefit of the respective community, the Company may advance certain amounts of money to a physician to assist in establishing his or her practice.
	The Company accounts for its physician minimum revenue guarantees in accordance with the provisions of ASC 460-10, “Guarantees” (“ASC 460-10”). In accordance with ASC 460-10, the Company records a contract-based intangible asset and a related guarantee liability for new physician minimum revenue guarantees. The contract-based intangible asset is amortized over the period of the physician contract, which typically ranges from four to five years and is included as an expense under the caption “Other operating expenses” in the accompanying unaudited condensed consolidated statements of operations. As of June 30, 2014 and December 31, 2013, the Company’s liability for contract-based physician minimum revenue guarantees was $10.5 million and $11.5 million, respectively. These amounts are included as a current liability under the caption “Other current liabilities” in the Company’s accompanying unaudited condensed consolidated balance sheets.
	Non-Competition Agreements
	The Company has entered into non-competition agreements with certain physicians and other individuals which are amortized on a straight-line basis over the term of the agreements.
	Certificates of Need and Certificates of Need Exemptions
	The construction or acquisition of new facilities, the expansion of existing facilities and the addition of new services and certain equipment at the Company’s facilities may be subject to state laws that require prior approval by state regulatory agencies. These certificate of need laws generally require that a state agency determine the public need and give approval prior to the construction or acquisition of facilities or the addition of new services. The Company operates hospitals in certain states that have adopted certificate of need laws.  The Company has determined that these intangible assets have an indefinite useful life.
	Licenses, Provider Numbers, Accreditations and Other
	To operate hospitals, the Company must obtain certain licenses, provider numbers and accreditations from federal, state and other accrediting agencies.  The Company has determined that these intangible assets have an indefinite useful life.

LongTerm_Debt

Long-Term Debt	6 Months Ended
	Jun. 30, 2014
Long-Term Debt [Abstract]	'
Long-Term Debt	'
	Note 7. Long-Term Debt
	Issuance of Additional 5.5% Senior Notes
	Effective May 12, 2014, the Company issued in a private placement $400.0 million of additional 5.5% Senior Notes with terms substantially identical to those of the initial offering of the 5.5% Senior Notes completed on December 6, 2013.  The additional notes were issued at a premium of $12.0 million for total net proceeds from the issuance of $412.0 million which were used to fund, in part, the cash-settled portion of the maturity or conversion of the 3½% Notes on or before May 15, 2014.  Including the impact of the premium, the additional 5.5% Senior Notes were issued at an effective rate of 4.9%.  In connection with the issuance of the additional 5.5% Senior Notes, the Company capitalized $5.5 million of deferred loan costs.
	Maturity and Conversion of 3½% Notes
	Effective May 15, 2014, the 3½% Notes matured. Prior to maturity, certain holders of the 3½% Notes exercised their right to convert per $1,000 in principal held for (i) an amount in cash, equal to the sum of, for each of the 20 volume-weighted average price trading days during the conversion period, the lesser of the daily conversion value for such volume-weighted average price trading day and $50; and (ii) a number of shares of the Company’s common stock in an amount equal to the sum of, for each of the 20 volume-weighted average price trading days during the conversion period, any excess of the daily conversion value above $50. Upon maturity and conversion of the 3½% Notes, the Company delivered to the holders cash of approximately $574.2 million and approximately 0.6 million shares of its common stock previously held in treasury at an average historical cost basis of $35.86 per share, or $23.0 million.

Income_Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2014
Income Taxes [Abstract]	'
Income Taxes	'
	Note 8.  Income Taxes
	The Company’s income tax provision was $37.8 million for an effective income tax rate of 33.2% during the six months ended June 30, 2014 as compared to $37.0 million for an effective income tax rate of 38.4% during the six months ended June 30, 2013.  The Company’s effective income tax rate was lower during the six months ended June 30, 2014 as a result of the reversal of a previously established valuation allowance against its deferred tax assets for federal net operating losses generated by the Company’s physician practice operations in the state of Michigan, which were previously thought to be unrecoverable.  The impact of the reversal during the six months ended June 30, 2014 resulted in an increase to net income of $6.0 million, or $0.13 per diluted share.

Common_Stock_In_Treasury

Common Stock In Treasury	6 Months Ended
	Jun. 30, 2014
Common Stock In Treasury [Abstract]	'
Common Stock In Treasury	'
	Note 9. Common Stock in Treasury
	The Company’s Board of Directors has authorized the repurchase of outstanding shares of its common stock either in the open market or through privately negotiated transactions, subject to market conditions, regulatory constraints and other customary factors in accordance with a repurchase plan adopted in 2011, as subsequently amended and extended in February 2013 (the “2011 Repurchase Plan”) and a repurchase plan adopted in the first quarter of 2014 (the “2014 Repurchase Plan”).  The 2011 Repurchase Plan provided for the repurchase of up to $350.0 million in shares of the Company’s common stock, and the Company has repurchased all shares authorized for repurchase under this plan. The 2014 Repurchase Plan provides for the repurchase of up to $150.0 million in shares of the Company’s common stock through October 1, 2015. The Company is not obligated to repurchase any specific number of shares under the 2014 Repurchase Plan.  The Company has designated the shares repurchased in accordance with its repurchase plans as treasury stock.
	In connection with the 2011 Repurchase Plan, the Company repurchased approximately 0.6 million and 3.0 million shares for an aggregate purchase price, including commissions, of $36.1 million and $164.7 million at an average purchase price of $58.69 and $54.33 per share during the three and six months ended June 30, 2014, respectively.   There were no repurchases made in accordance with the 2011 Repurchase Plan during the three or six months ended June 30, 2013.  As of June 30, 2014, the Company had remaining authority to repurchase the entire  $150.0 million in shares in accordance with the 2014 Repurchase Plan.
	Additionally, the Company redeems shares from employees for minimum statutory tax withholding purposes upon vesting of certain stock awards granted pursuant to the Company’s various stockholder approved stock-based compensation plans. The Company redeemed approximately 0.1 million and 0.2 million shares vested under these plans during the six months ended June 30, 2014 and 2013, respectively, for an aggregate purchase price of approximately $7.2 million during each of the six months ended June 30, 2014 and 2013, respectively. The Company has designated these shares as treasury stock. Furthermore, as more fully discussed in Note 7, upon the conversion of the 3½% Notes on or before May 15, 2014, the Company delivered to holders of the 3½% Notes approximately 0.6 million shares of its common stock previously held in treasury at an average historical cost basis of $35.86 per share, or $23.0 million.

StockBased_Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2014
Stock-Based Compensation [Abstract]	'
Stock-Based Compensation	'
	Note 10. Stock-Based Compensation
	Overview
	The Company issues stock-based awards, including stock options and other stock-based awards (nonvested stock, restricted stock, restricted stock units and performance shares) to certain officers, employees and non-employee directors in accordance with the Company’s various stockholder-approved stock-based compensation plans. The Company accounts for its stock-based awards in accordance with the provisions of ASC 718-10, “Compensation – Stock Compensation” (“ASC 718-10”), and accordingly recognizes compensation expense over each of the stock-based award’s requisite service period based on the estimated grant date fair value.
	Effective June 4, 2013, upon the approval of the Company’s stockholders, the Company replaced the Amended and Restated 1998 Long-Term Incentive Plan (the “1998 LTIP”) and the Amended and Restated Outside Directors Stock and Incentive Compensation Plan (the “ODSICP”) with the 2013 Long-Term Incentive Plan (the “2013 LTIP”), a new combined plan covering all of the Company’s employees and non-employee directors.  The 2013 LTIP provides for 3.6 million shares available for grant at a rate of 1.00 share for each stock option or appreciation rights award granted and 2.09 shares for each full-value award granted.  No shares remain available for new awards to be granted under the 1998 LTIP or the ODSICP.
	Stock Options
	The Company granted options to purchase 712,950 shares of the Company’s common stock to certain officers and employees in accordance with the 2013 LTIP during the six months ended June 30, 2014.  Additionally, the Company granted options to purchase 735,200 shares of the Company’s common stock to certain officers and employees in accordance with the 1998 LTIP during the six months ended June 30, 2013 prior to its replacement with the 2013 LTIP.  Options to purchase shares granted to the Company’s officers and employees in accordance with the 2013 LTIP and the 1998 LTIP were granted with an exercise price equal to the fair market value of the Company’s common stock on the day of grant, determined based on the closing price on the trading date immediately prior to the grant date. The options granted during the six months ended June 30, 2014 and 2013 become ratably exercisable beginning one year from the date of grant to three years after the date of grant and expire ten years from the date of grant.
	The Company estimated the fair value of stock options granted using the Hull-White II (“HW-II”) lattice option valuation model and a single option award approach.  The Company uses HW-II because it considers characteristics of fair value option pricing, such as an option’s contractual term and the probability of exercise before the end of the contractual term.  In addition, the complications surrounding the expected term of an option are material, as indicated in ASC 718-10.  Given the Company’s relatively large pool of unexercised options, the Company believes a lattice model that specifically addresses this fact and models a full term of exercises is the most appropriate and reliable means of valuing its stock options.  The Company is amortizing the fair value on a straight-line basis over the requisite service period of the awards, which is the vesting period of three years.  The stock options vest 33.3% on each grant anniversary date over three years of continued employment.
	The following table shows the weighted average assumptions the Company used to develop the fair value estimates under its HW-II option valuation model and the resulting estimates of weighted-average fair value per share of stock options granted during the six months ended June 30, 2014 and 2013:
		Six Months Ended June 30,
		2014				2013
	Expected volatility		29.0	%			31.0	%
	Risk-free interest rate, minimum		0.05	%			0.05	%
	Risk-free interest rate, maximum		2.71	%			1.95	%
	Expected dividends		-				-
	Average expected term (years)		5.4				5.3
	Fair value per share of stock options granted	$	13.95			$	11.97
	The total intrinsic value of stock options exercised during the six months ended June 30, 2014 and 2013 was $9.5 million and $8.7 million, respectively. The Company received $11.1 million and $4.6 million in cash from stock option exercises for the three months ended June 30, 2014 and 2013, respectively, and $18.3 million and $28.2 million in cash from stock option exercises for the six months ended June 30, 2014 and 2013, respectively.  The actual tax benefit realized for the tax deductions from stock option exercises was $1.2 million and $0.1 million for the six months ended June 30, 2014 and 2013, respectively.
	As of June 30, 2014, there was $14.0 million of total estimated unrecognized compensation cost related to stock option compensation arrangements. Total estimated unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. The Company expects to recognize that cost over a weighted average period of 1.4 years.
	Other Stock-Based Awards
	The Company granted 366,271 and 23,912 restricted stock units to certain officers, employees and non-employee directors in accordance with the 2013 LTIP during the six months ended June 30, 2014 and 2013, respectively.  Additionally, the Company granted 410,000 restricted stock units to certain officers and employees in accordance with the 1998 LTIP during the six months ended June 30, 2013 prior to its replacement with the 2013 LTIP. Excluding the fair value of the performance-based awards granted during the six months ended June 30, 2014, the fair value of these restricted stock units was determined based on the closing price of the Company’s common stock on the day prior to the grant date. The restricted stock units granted during the six months ended June 30, 2014 and 2013 have either cliff-vesting periods from the grant date of three years, cliff-vesting periods from the grant date of six months and one day or ratable vesting periods beginning one year from the date of grant to three years after the date of grant.
	Of the restricted stock units granted during the six months ended June 30, 2014, 236,000 were performance-based awards.  In addition to requiring continuing service of the employee, the percentage of these restricted stock units that are earned at the end of the performance period is determined based on the Company’s three-year annualized total shareholder return relative to a peer group, Standard and Poor’s Global Industry Classification Standard’s Sub-industry:  Health Care Facilities with over $500.0 million in revenues or its equivalent. The number of shares payable at the end of the three-year performance period ranges from 0% to 100% of the targeted units, with any portion of the award that exceeds 100% up to 200% of the targeted units settled in cash equal to the fair market value on the date certification of the level of performance is achieved.  For valuation purposes, the awards were bifurcated into their two independent sub-award components for the portion that would be settled in the Company’s common stock and for the portion that would be settled in cash and their respective fair values were estimated using the Monte-Carlo simulation valuation model.  The Company recognizes compensation expense for the portion of the award that would ultimately be settled in the Company’s common stock for the targeted units at its Monte-Carlo simulation value if the requisite service period is rendered, even if the market condition is never satisfied.  The Company will classify as a liability and recognize compensation expense for the portion of the award that would ultimately be settled in cash for the targeted units at its Monte-Carlo simulation value that will be marked-to-market until settlement.
	Of the restricted stock units granted during the six months ended June 30, 2013,  307,000 were performance-based awards that, in addition to requiring continuing service of an employee, the vesting of which is contingent upon the satisfaction of certain financial goals, specifically related to the achievement of targeted annual revenues or earnings goals within a three-year period. If these goals are achieved, the performance-based awards will cliff-vest three years after the grant date. The performance criteria for the 307,000 performance-based awards granted during the six months ended June 30, 2013 have not been met and are still subject to continuing service requirements and the three year cliff-vesting provisions.  For purposes of estimating compensation expense for these performance-based awards, the Company has assumed that the performance goals will be achieved. If the performance goals are not met for these performance-based awards, no compensation expense will be recognized, and any previously recognized compensation expense will be reversed.
	Notwithstanding the specific grant vesting requirements, award agreements under the 2013 LTIP and the 1998 LTIP may provide for accelerated vesting in certain circumstances.  Generally, award agreements provide for full vesting upon the death or disability of the participant.  Some award agreements also provide for partial or full vesting upon involuntary termination of employment, provided that if the award is performance-based then the accelerated vesting would occur only if the performance goals are attained.
	As of June 30, 2014,  there was $29.9 million of total estimated unrecognized compensation cost related to other stock-based awards. Total estimated unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. The Company expects to recognize that cost over a weighted average period of 1.9 years.
	The following table summarizes the Company’s total stock-based compensation expense as well as the total recognized tax benefits related thereto for the three and six months ended June 30, 2014 and 2013 (in millions):
		Three Months Ended						Six Months Ended
		June 30,						June 30,
		2014			2013			2014		2013
	Equity awards:
	Other stock-based awards	$	4.2		$	4.2		$	8.5	$	8.2
	Stock options		2.2			2.1			4.6		4.9
			6.4			6.3			13.1		13.1
	Liability awards:
	Other stock-based awards		0.5			-			0.7		-
	Total stock-based compensation expense	$	6.9		$	6.3		$	13.8	$	13.1
	Tax benefit on stock-based compensation expense	$	2.7		$	2.5		$	5.5	$	5.3
	The Company did not capitalize any stock-based compensation cost during the three or six months ended June 30, 2014 or 2013. As of June 30, 2014, there was $43.9 million of total estimated unrecognized compensation cost related to all of the Company’s stock-based compensation arrangements. Total estimated unrecognized compensation cost may be adjusted for future changes in estimated forfeitures. The Company expects to recognize that cost over a weighted-average period of 1.8 years.

Commitments_And_Contingencies

Commitments And Contingencies	6 Months Ended
	Jun. 30, 2014
Commitments And Contingencies [Abstract]	'
Commitments And Contingencies	'
	Note 11. Commitments and Contingencies
	Legal Proceedings and General Liability Claims
	Hospitals are, from time to time, subject to claims and suits arising in the ordinary course of business, including claims for damages for personal injuries, medical malpractice, breach of contracts, wrongful restriction of or interference with physicians’ staff privileges and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages that may not be covered by insurance.
	In addition, hospitals are subject to the regulation and oversight of various state and federal governmental agencies. Further, under the federal False Claims Act, private parties have the right to bring qui tam, or “whistleblower,” suits against hospitals that submit false claims for payments to, or improperly retain overpayments from, governmental payors. Some states have adopted similar state whistleblower and false claims provisions. Although the healthcare industry has seen numerous ongoing investigations related to compliance and billing practices, hospitals, in particular, continue to be a primary enforcement target for the Office of the Inspector General (“OIG”), the Department of Justice (“DOJ”) and other governmental fraud and abuse programs. Certain of the Company’s individual facilities have received, and from time to time, other facilities may receive, inquiries from federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material adverse effect on the Company’s financial position, results of operations and liquidity.
	The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 imposed an affirmative obligation on healthcare providers to report and refund any overpayments received. “Overpayments” in this context include any amount received from a government program by a provider to which it is not entitled, regardless of the cause. Such overpayments are deemed to be fraudulent and become violations of the False Claims Act if not reported and refunded within 60 days of identification. Hospitals can meet the obligation to report and refund in three ways: (1) refunding overpayments directly to the program; (2) self-disclosing the overpayment to the OIG via its voluntary self-disclosure protocol (with respect to False Claims Act and other violations not related to the Stark law); and (3) self-disclosing to the Centers for Medicare and Medicaid Services (“CMS”) via the self-referral disclosure protocol (with respect to overpayments caused by potential violations of the Stark law only) for which CMS has the authority to reduce the amounts otherwise owed.
	In connection with the Company’s acquisition of Marquette General Health System, Marquette General Hospital, Inc. (the “Marquette Seller”) self-disclosed various potentially non-compliant physician arrangements under the CMS voluntary self-disclosure protocol.  The self-disclosure is pending with CMS.  To the extent that the Marquette Seller’s satisfaction of its retained liabilities, including those under its CMS voluntary self-disclosure, causes its net proceeds from the acquisition to be less than $15.0 million, the Company has agreed to pay additional purchase consideration to the Marquette Seller.  The Company has made reasonable estimates of these potential liabilities and at June 30, 2014 has recorded an aggregate of $18.0 million representing the fair values of its potential obligation to the Marquette Seller.  The Company’s management does not control and cannot predict with certainty the progress or final outcome of any discussions with third parties, such as government agencies.  Therefore, the final amounts paid in settlement of these contingent obligations, if any, could materially differ from amounts currently recorded.  Any such changes in estimate will impact the Company’s future results of operations and cash flows.
	On September 16, 2013, the Company and two of its hospitals made a voluntary self-disclosure to the Civil Division of the DOJ.  The voluntary self-disclosure relates to concerns regarding the medical necessity of certain interventional cardiology procedures conducted by one physician in each of these hospitals’ cardiac catheterization laboratories.  On September 24, 2013, the U.S. Attorney’s Office in the district in which one of these hospitals is located served a subpoena requesting information related to the subject matter of the voluntary self-disclosure.  The hospital that received the subpoena has produced responsive documents, including patient files, on a rolling basis.  The Company is cooperating with the government in addressing these matters and is conducting an internal review of the procedures performed by these physicians.
	Physician Commitments
	The Company has committed to provide certain financial assistance pursuant to recruiting agreements with various physicians practicing in the communities it serves.  In consideration for a physician’s relocating to one of its communities and agreeing to engage in private practice for the benefit of the respective community, the Company may advance certain amounts of money to a physician, normally over a period of one year, to assist in establishing the physician’s practice.  The Company has committed to advance a maximum amount of approximately $27.5 million at June 30, 2014.  The actual amount of such commitments to be subsequently advanced to physicians is estimated at $10.5 million and often depends upon the financial results of a physician’s private practice during the guarantee period.  Generally, amounts advanced under the recruiting agreements may be forgiven pro rata over a period of 36 to 48 months contingent upon the physician continuing to practice in the respective community.  Pursuant to the Company’s standard physician recruiting agreement, any breach or non-fulfillment by a physician under the physician recruiting agreement gives the Company the right to recover any payments made to the physician under the agreement.  Additionally, the Company is subject to annual commitments for certain physician recruiting activities, including the continuation of existing or initiation of new activities with several of its facilities.
	Capital Expenditure Commitments
	The Company is reconfiguring some of its hospitals to more effectively accommodate patient services and to provide for a greater variety of services, as well as implementing various information system initiatives in its efforts to comply with the Health Information Technology for Economic and Clinical Health Act. The Company has incurred approximately $60.1 million in costs related to uncompleted projects as of June 30, 2014, which is included under the caption “Construction in progress” in the Company’s accompanying unaudited condensed consolidated balance sheet. At June 30, 2014, these uncompleted projects had an estimated cost to complete and equip of approximately $72.8 million.  Additionally, the Company is subject to annual capital expenditure commitments in connection with several of its facilities.  As part of the Company’s current acquisition strategy, management expects capital expenditure commitments to be a significant component of future purchase transactions.
	Acquisitions
	The Company has historically acquired businesses with prior operating histories. Acquired businesses may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, medical and general professional liabilities, workers compensation liabilities, previous tax liabilities and unacceptable business practices. Although the Company institutes policies designed to conform practices to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. Although the Company generally seeks to obtain indemnification from prospective sellers covering such matters, there can be no assurance that any such matter will be covered by indemnification, or if covered, that such indemnification will be adequate to cover potential losses and fines.

Earnings_Per_Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	Note 12. Earnings Per Share
	The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2014 and 2013 (dollars and shares in millions, except per share amounts):
		Three Months Ended				Six Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Numerator for basic and diluted earnings per share
	attributable to LifePoint Hospitals, Inc.:
	Income from continuing operations	$	41.8	$	27.2	$	79.5	$	60.2
	Less: Net income attributable to noncontrolling interests
	and redeemable noncontrolling interests		-2.7		-0.1		-3.3		-0.8
	Income from continuing operations attributable to
	LifePoint Hospitals, Inc. stockholders		39.1		27.1		76.2		59.4
	Income from discontinued operations, net of income taxes		-		0.3		-		0.4
	Net income attributable to LifePoint Hospitals, Inc.	$	39.1	$	27.4	$	76.2	$	59.8
	Denominator:
	Weighted average shares outstanding - basic		44.5		46.5		45.2		46.2
	Effect of dilutive securities:
	Stock options and other stock-based awards		1.7		1.2		1.6		1.3
	Convertible debt instruments		0.3		-		0.5		-
	Weighted average shares outstanding - diluted		46.5		47.7		47.3		47.5
	Basic earnings per share attributable to LifePoint Hospitals,
	Inc. stockholders:
	Continuing operations	$	0.88	$	0.58	$	1.69	$	1.29
	Discontinued operations		-		0.01		-		0.01
	Net income	$	0.88	$	0.59	$	1.69	$	1.30
	Diluted earnings per share attributable to LifePoint Hospitals,
	Inc. stockholders:
	Continuing operations	$	0.84	$	0.57	$	1.61	$	1.25
	Discontinued operations		-		-		-		0.01
	Net income	$	0.84	$	0.57	$	1.61	$	1.26
	The Company’s convertible debt instruments are included in the calculation of diluted earnings per share whether or not the contingent requirements have been met for conversion if their conversion price is less than the average market price of the Company’s common stock for the period. Upon conversion, the par value is settled in cash, and only the conversion premium is settled in shares of the Company’s common stock. Additionally, certain outstanding stock-based awards have been excluded from the calculation of diluted earnings per share to the extent they were anti-dilutive for the three or six months ended June 30, 2014 and 2013.

Guarantor_And_NonGuarantor_Sup

Guarantor And Non-Guarantor Supplementary Information	6 Months Ended
	Jun. 30, 2014
Guarantor And Non-Guarantor Supplementary Information [Abstract]	'
Guarantor And Non-Guarantor Supplementary Information	'
	Note 13. Guarantor and Non-Guarantor Supplementary Information
	The 6.625% Senior Notes and the 5.5% Senior Notes are jointly and severally guaranteed on an unsecured senior basis by substantially all of the Company’s existing subsidiaries that guarantee the Senior Credit Agreement. The guarantees are subject to customary release provisions set forth in the agreements for the 6.625% Senior Notes and the 5.5% Senior Notes.
	The condensed consolidating financial information for the parent issuer, guarantor subsidiaries, non-guarantor subsidiaries, certain eliminations and the Company is presented below for the three and six months ended June 30, 2014 and 2013 and as of June 30, 2014 and December 31, 2013.  Prior year amounts have been reclassified to conform to current year presentation.
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended June 30, 2014
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	861.8	$	384.4	$	-	$	1,246.2
	Provision for doubtful accounts		-		140.4		58.8		-		199.2
	Revenues		-		721.4		325.6		-		1,047.0
	Salaries and benefits		6.9		323.5		158.1		-		488.5
	Supplies		-		104.4		58.1		-		162.5
	Other operating expenses		-		187.2		71.1		-		258.3
	Other income		-		-15.2		-5.8		-		-21
	Equity in earnings of affiliates		-57.6		-		-		57.6		-
	Depreciation and amortization		-		46.1		14.8		-		60.9
	Interest expense, net		11.8		17.7		1.8		-		31.3
	Management (income) fees		-		-4.9		4.9		-		-
			-38.9		658.8		303.0		57.6		980.5
	Income from continuing operations
	before taxes		38.9		62.6		22.6		-57.6		66.5
	(Benefit) provision for income taxes		-0.2		24.9		-		-		24.7
	Net income		39.1		37.7		22.6		-57.6		41.8
	Less:  Net income attributable to
	noncontrolling interests and
	redeemable noncontrolling interests		-		-0.2		-2.5		-		-2.7
	Net income attributable to LifePoint
	Hospitals, Inc.	$	39.1	$	37.5	$	20.1	$	-57.6	$	39.1
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended June 30, 2013
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	815.6	$	260.1	$	-	$	1,075.7
	Provision for doubtful accounts		-		141.5		39.3		-		180.8
	Revenues		-		674.1		220.8		-		894.9
	Salaries and benefits		6.3		312.1		103.7		-		422.1
	Supplies		-		102.3		41.8		-		144.1
	Other operating expenses		0.1		171.5		51.3		-		222.9
	Other income		-		-9.9		-1.1		-		-11
	Equity in earnings of affiliates		-38		-		-		38.0		-
	Depreciation and amortization		-		43.4		12.5		-		55.9
	Interest expense, net		3.3		17.1		2.2		-		22.6
	Gain on settlement of pre-acquisition
	contingent obligation		-		-		-5.6		-		-5.6
	Management (income) fees		-		-3.2		3.2		-		-
			-28.3		633.3		208.0		38.0		851.0
	Income from continuing operations
	before taxes		28.3		40.8		12.8		-38		43.9
	Provision for income taxes		0.9		15.8		-		-		16.7
	Income from continuing operations		27.4		25.0		12.8		-38		27.2
	Income from discontinued operations,
	net of taxes		-		0.3		-		-		0.3
	Net income		27.4		25.3		12.8		-38		27.5
	Less:  Net (income) loss attributable
	to noncontrolling interests and
	redeemable noncontrolling interests		-		-0.3		0.2		-		-0.1
	Net income attributable to LifePoint
Hospitals, Inc.	$	27.4	$	25.0	$	13.0	$	-38	$	27.4
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Operations
For the Six Months Ended June 30, 2014
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Revenues before provision for
doubtful accounts	$	-	$	1,699.8	$	729.2	$	-	$	2,429.0
Provision for doubtful accounts		-		268.7		106.1		-		374.8
Revenues		-		1,431.1		623.1		-		2,054.2
Salaries and benefits		13.8		648.0		301.5		-		963.3
Supplies		-		207.1		112.4		-		319.5
Other operating expenses		-		367.9		133.9		-		501.8
Other income		-		-28.8		-6.1		-		-34.9
Equity in earnings of affiliates		-113.9		-		-		113.9		-
Depreciation and amortization		-		91.4		30.6		-		122.0
Interest expense, net		26.1		34.7		4.4		-		65.2
Management (income) fees		-		-10		10.0		-		-
		-74		1,310.3		586.7		113.9		1,936.9
Income from continuing operations
before taxes		74.0		120.8		36.4		-113.9		117.3
(Benefit) provision for income taxes		-2.2		40.0		-		-		37.8
Net income		76.2		80.8		36.4		-113.9		79.5
Less:  Net income attributable to
noncontrolling interests and
redeemable noncontrolling interests		-		-0.4		-2.9		-		-3.3
Net income attributable to LifePoint
Hospitals, Inc.	$	76.2	$	80.4	$	33.5	$	-113.9	$	76.2
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Operations
For the Six Months Ended June 30, 2013
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Revenues before provision for
doubtful accounts	$	-	$	1,658.4	$	517.5	$	-	$	2,175.9
Provision for doubtful accounts		-		275.7		74.2		-		349.9
Revenues		-		1,382.7		443.3		-		1,826.0
Salaries and benefits		13.1		631.8		210.4		-		855.3
Supplies		-		202.9		85.9		-		288.8
Other operating expenses		0.5		345.7		98.2		-		444.4
Other income		-		-15.6		-1.1		-		-16.7
Equity in earnings of affiliates		-82.9		-		-		82.9		-
Depreciation and amortization		-		87.0		24.7		-		111.7
Interest expense, net		8.1		34.0		4.4		-		46.5
Gain on settlement of pre-acquisition
contingent obligation		-		-		-5.6		-		-5.6
Debt transaction costs		4.4		-		-		-		4.4
Management (income) fees		-		-6.5		6.5		-		-
		-56.8		1,279.3		423.4		82.9		1,728.8
Income from continuing operations
before taxes		56.8		103.4		19.9		-82.9		97.2
(Benefit) provision for income taxes		-3		40.0		-		-		37.0
Income from continuing operations		59.8		63.4		19.9		-82.9		60.2
Income from discontinued operations,
net of taxes		-		0.4		-		-		0.4
Net income		59.8		63.8		19.9		-82.9		60.6
Less:  Net income attributable to
noncontrolling interests and
redeemable noncontrolling interests		-		-0.3		-0.5		-		-0.8
Net income attributable to LifePoint
Hospitals, Inc.	$	59.8	$	63.5	$	19.4	$	-82.9	$	59.8
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Balance Sheets
30-Jun-14
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	-	$	234.9	$	107.1	$	-	$	342.0
Accounts receivable, net		-		472.0		174.4		-		646.4
Inventories		-		73.0		33.9		-		106.9
Prepaid expenses		0.3		29.1		9.3		-		38.7
Deferred tax assets		130.1		-		-		-		130.1
Other current assets		16.8		50.9		38.8		-		106.5
		147.2		859.9		363.5		-		1,370.6
Property and equipment:
Land		-		73.8		55.6		-		129.4
Buildings and improvements		-		1,578.2		487.5		-		2,065.7
Equipment		-		1,271.7		254.1		-		1,525.8
Construction in progress		-		41.3		18.8		-		60.1
		-		2,965.0		816.0		-		3,781.0
Accumulated depreciation		-		-1,380.40		-183.2		-		-1,563.60
		-		1,584.6		632.8		-		2,217.4
Deferred loan costs, net		33.5		-		-		-		33.5
Intangible assets, net		-		37.3		34.1		-		71.4
Investments in subsidiaries		1,959.4		-		-		-1,959.40		-
Due from subsidiaries		2,399.8		-		-		-2,399.80		-
Other		4.7		19.3		14.5		-		38.5
Goodwill		-		1,435.4		194.7		-		1,630.1
Total assets	$	4,544.6	$	3,936.5	$	1,239.6	$	-4,359.20	$	5,361.5
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	-	$	101.0	$	47.1	$	-	$	148.1
Accrued salaries		-		102.6		44.0		-		146.6
Other current liabilities		12.9		122.0		50.5		-		185.4
Current maturities of long-term debt		11.3		0.6		1.0		-		12.9
		24.2		326.2		142.6		-		493.0
Long-term debt		2,149.4		49.5		3.6		-		2,202.5
Due to Parent		-		1,914.4		485.4		-2,399.80		-
Deferred income tax liabilities		203.8		-		-		-		203.8
Long-term portion of reserves for self-insurance claims		-		104.8		29.1		-		133.9
Other long-term liabilities		-		20.6		35.7		-		56.3
Long-term income tax liability		18.9		-		-		-		18.9
Total liabilities		2,396.3		2,415.5		696.4		-2,399.80		3,108.4
Redeemable noncontrolling interests		-		-		84.7		-		84.7
Total LifePoint Hospitals, Inc. stockholders' equity		2,148.3		1,519.7		439.7		-1,959.40		2,148.3
Noncontrolling interests		-		1.3		18.8		-		20.1
Total equity		2,148.3		1,521.0		458.5		-1,959.40		2,168.4
Total liabilities and equity	$	4,544.6	$	3,936.5	$	1,239.6	$	-4,359.20	$	5,361.5
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Balance Sheets
December 31, 2013
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	-	$	558.3	$	79.6	$	-	$	637.9
Accounts receivable, net		-		444.3		151.4		-		595.7
Inventories		-		73.4		28.6		-		102.0
Prepaid expenses		0.1		30.6		7.3		-		38.0
Deferred tax assets		147.7		-		-		-		147.7
Other current assets		-		53.0		19.9		-		72.9
		147.8		1,159.6		286.8		-		1,594.2
Property and equipment:
Land		-		76.0		36.3		-		112.3
Buildings and improvements		-		1,570.1		449.5		-		2,019.6
Equipment		-		1,256.4		213.5		-		1,469.9
Construction in progress		-		45.6		13.1		-		58.7
		-		2,948.1		712.4		-		3,660.5
Accumulated depreciation		-		-1,309.00		-154.3		-		-1,463.30
		-		1,639.1		558.1		-		2,197.2
Deferred loan costs, net		31.1		-		-		-		31.1
Intangible assets, net		-		40.3		32.3		-		72.6
Investments in subsidiaries		1,853.1		-		-		-1,853.10		-
Due from subsidiaries		2,760.4		-		-		-2,760.40		-
Other		3.4		22.4		14.9		-		40.7
Goodwill		-		1,435.1		215.9		-		1,651.0
Total assets	$	4,795.8	$	4,296.5	$	1,108.0	$	-4,613.50	$	5,586.8
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	-	$	99.1	$	36.8	$	-	$	135.9
Accrued salaries		-		102.1		37.5		-		139.6
Other current liabilities		14.8		146.4		36.0		-		197.2
Current maturities of long-term debt		581.4		0.7		0.9		-		583.0
		596.2		348.3		111.2		-		1,055.7
Long-term debt		1,739.8		50.0		4.0		-		1,793.8
Due to Parent		-		2,324.8		435.6		-2,760.40		-
Deferred income tax liabilities		233.1		-		-		-		233.1
Long-term portion of reserves for self-insurance claims		-		113.5		26.3		-		139.8
Other long-term liabilities		-		20.2		35.2		-		55.4
Long-term income tax liability		16.6		-		-		-		16.6
Total liabilities		2,585.7		2,856.8		612.3		-2,760.40		3,294.4
Redeemable noncontrolling interests		-		-		59.8		-		59.8
Total LifePoint Hospitals, Inc. stockholders' equity		2,210.1		1,438.2		414.9		-1,853.10		2,210.1
Noncontrolling interests		-		1.5		21.0		-		22.5
Total equity		2,210.1		1,439.7		435.9		-1,853.10		2,232.6
Total liabilities and equity	$	4,795.8	$	4,296.5	$	1,108.0	$	-4,613.50	$	5,586.8
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Three Months Ended June 30, 2014
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	39.1	$	37.7	$	22.6	$	-57.6	$	41.8
Adjustments to reconcile net income to net cash provided
by operating activities:
Equity in earnings of affiliates		-57.6		-		-		57.6		-
Stock-based compensation		6.4		-		-		-		6.4
Depreciation and amortization		-		46.1		14.8		-		60.9
Amortization of physician minimum revenue guarantees		-		3.3		0.5		-		3.8
Amortization of debt discounts, premium and deferred loan costs		4.3		-		-		-		4.3
Deferred income taxes		36.5		-		-		-		36.5
Reserve for self-insurance claims, net of payments		-		-1.4		-		-		-1.4
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		2.9		19.3		-		22.2
Inventories and other current assets		-0.3		-5.2		2.8		-		-2.7
Accounts payable and accrued expenses		-21		-16.6		6.3		-		-31.3
Income taxes payable/receivable		-71.8		-		-		-		-71.8
Other		-		0.2		-0.9		-		-0.7
Net cash (used in) provided by operating activities		-64.4		67.0		65.4		-		68.0
Cash flows from investing activities:
Purchases of property and equipment		-		-21.6		-9.6		-		-31.2
Acquisitions, net of cash acquired		-		-		-27.2		-		-27.2
Other		-0.4		1.0		-0.5		-		0.1
Net cash used in investing activities		-0.4		-20.6		-37.3		-		-58.3
Cash flows from financing activities:
Proceeds from borrowings		412.0		-		-		-		412.0
Payments of borrowings		-579.8		-		-		-		-579.8
Repurchases of common stock		-36.1		-		-		-		-36.1
Payment of debt financing costs		-5.5		-		-		-		-5.5
Proceeds from exercise of stock options		11.1		-		-		-		11.1
Change in intercompany balances with affiliates, net		263.2		-253.2		-10		-		-
Other		-0.1		-0.1		-1.5		-		-1.7
Net cash provided by (used in) financing activities		64.8		-253.3		-11.5		-		-200
Change in cash and cash equivalents		-		-206.9		16.6		-		-190.3
Cash and cash equivalents at beginning of period		-		441.8		90.5		-		532.3
Cash and cash equivalents at end of period	$	-	$	234.9	$	107.1	$	-	$	342.0
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Three Months Ended June 30, 2013
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	27.4	$	25.3	$	12.8	$	-38	$	27.5
Adjustments to reconcile net income to net cash provided
by operating activities:
Income from discontinued operations		-		-0.3		-		-		-0.3
Equity in earnings of affiliates		-38		-		-		38.0		-
Stock-based compensation		6.3		-		-		-		6.3
Depreciation and amortization		-		43.4		12.5		-		55.9
Amortization of physician minimum revenue guarantees		-		4.2		0.3		-		4.5
Amortization of debt discounts and deferred loan costs		6.0		-		-		-		6.0
Gain on settlement of contingent obligation		-		-		-5.6		-		-5.6
Deferred income tax benefit		-36.6		-		-		-		-36.6
Reserve for self-insurance claims, net of payments		-		0.2		1.9		-		2.1
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		1.0		9.9		-		10.9
Inventories and other current assets		-0.1		12.2		-1.2		-		10.9
Accounts payable and accrued expenses		-11.8		-8.1		4.1		-		-15.8
Income taxes payable/receivable		-7.5		-		-		-		-7.5
Other		-0.1		-0.5		-0.2		-		-0.8
Net cash (used in) provided by operating activities - continuing
operations		-54.4		77.4		34.5		-		57.5
Net cash used in operating activities - discontinued operations		-		-0.6		-		-		-0.6
Net cash (used in) provided by operating activities		-54.4		76.8		34.5		-		56.9
Cash flows from investing activities:
Purchases of property and equipment		-		-28.5		-8.8		-		-37.3
Acquisitions, net of cash acquired		-		-4.9		-		-		-4.9
Other		-		0.2		1.0		-		1.2
Net cash used in investing activities		-		-33.2		-7.8		-		-41
Cash flows from financing activities:
Payments of borrowings		-3.6		-		-		-		-3.6
Repurchases of common stock		-0.1		-		-		-		-0.1
Payment of debt financing costs		-0.1		-						-0.1
Proceeds from exercise of stock options		4.6		-		-		-		4.6
Change in intercompany balances with affiliates, net		53.8		-28.5		-25.3		-		-
Other		-0.2		0.1		-2		-		-2.1
Net cash provided by (used in) financing activities		54.4		-28.4		-27.3		-		-1.3
Change in cash and cash equivalents		-		15.2		-0.6		-		14.6
Cash and cash equivalents at beginning of period		-		90.0		70.4		-		160.4
Cash and cash equivalents at end of period	$	-	$	105.2	$	69.8	$	-	$	175.0
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Six Months Ended June 30, 2014
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	76.2	$	80.8	$	36.4	$	-113.9	$	79.5
Adjustments to reconcile net income to net cash provided
by operating activities:
Equity in earnings of affiliates		-113.9		-		-		113.9		-
Stock-based compensation		13.1		-		-		-		13.1
Depreciation and amortization		-		91.4		30.6		-		122.0
Amortization of physician minimum revenue guarantees		-		6.9		0.8		-		7.7
Amortization of debt discounts, premium and deferred loan costs		11.6		-		-		-		11.6
Deferred income tax benefit		-5.1		-		-		-		-5.1
Reserve for self-insurance claims, net of payments		-		1.9		2.8		-		4.7
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		-29.3		1.0		-		-28.3
Inventories and other current assets		-0.2		18.6		2.0		-		20.4
Accounts payable and accrued expenses		0.7		-45.1		12.8		-		-31.6
Income taxes payable/receivable		-19.3		-		-		-		-19.3
Other		-0.1		1.5		0.5		-		1.9
Net cash (used in) provided by operating activities		-37		126.7		86.9		-		176.6
Cash flows from investing activities:
Purchases of property and equipment		-		-37.3		-16.4		-		-53.7
Acquisitions, net of cash acquired		-		-2.7		-85.1		-		-87.8
Other		-1.2		0.4		0.4		-		-0.4
Net cash used in investing activities		-1.2		-39.6		-101.1		-		-141.9
Cash flows from financing activities:
Proceeds from borrowings		412.0		-		-		-		412.0
Payments of borrowings		-579.8		-		-		-		-579.8
Repurchases of common stock		-171.9		-		-		-		-171.9
Payment of debt financing costs		-5.9		-		-		-		-5.9
Proceeds from exercise of stock options		18.3		-		-		-		18.3
Change in intercompany balances with affiliates, net		365.6		-410.4		44.8		-		-
Other		-0.1		-0.1		-3.1		-		-3.3
Net cash provided by (used in) financing activities		38.2		-410.5		41.7		-		-330.6
Change in cash and cash equivalents		-		-323.4		27.5		-		-295.9
Cash and cash equivalents at beginning of period		-		558.3		79.6		-		637.9
Cash and cash equivalents at end of period	$	-	$	234.9	$	107.1	$	-	$	342.0
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Six Months Ended June 30, 2013
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	59.8	$	63.8	$	19.9	$	-82.9	$	60.6
Adjustments to reconcile net income to net cash provided
by operating activities:
Income from discontinued operations		-		-0.4		-		-		-0.4
Equity in earnings of affiliates		-82.9		-		-		82.9		-
Stock-based compensation		13.1		-		-		-		13.1
Depreciation and amortization		-		87.0		24.7		-		111.7
Amortization of physician minimum revenue guarantees		-		8.2		0.8		-		9.0
Amortization of debt discounts and deferred loan costs		13.1		-		-		-		13.1
Gain on settlement of pre-acquisition contingent obligation		-		-		-5.6		-		-5.6
Debt transaction costs		4.4		-		-		-		4.4
Deferred income tax benefit		-43.7		-		-		-		-43.7
Reserve for self-insurance claims, net of payments		-		0.6		6.1		-		6.7
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		-23.6		5.0		-		-18.6
Inventories and other current assets		-		6.4		-1.6		-		4.8
Accounts payable and accrued expenses		-2.4		-31.8		8.2		-		-26
Income taxes payable/receivable		19.5		-		-		-		19.5
Other		-		0.4		0.3		-		0.7
Net cash (used in) provided by operating activities - continuing
operations		-19.1		110.6		57.8		-		149.3
Net cash used in operating activities - discontinued operations		-		-0.2		-		-		-0.2
Net cash (used in) provided by operating activities		-19.1		110.4		57.8		-		149.1
Cash flows from investing activities:
Purchases of property and equipment		-		-58.3		-17.5		-		-75.8
Acquisitions, net of cash acquired		-		-6.2		-		-		-6.2
Other		-0.2		0.6		1.0		-		1.4
Net cash used in investing activities		-0.2		-63.9		-16.5		-		-80.6
Cash flows from financing activities:
Proceeds from borrowings		323.0		-		-		-		323.0
Payments of borrowings		-317.2		-		-		-		-317.2
Repurchases of common stock		-7.2		-		-		-		-7.2
Payment of debt financing costs		-1		-		-		-		-1
Proceeds from exercise of stock options		28.2		-		-		-		28.2
Change in intercompany balances with affiliates, net		-6.3		33.8		-27.5		-		-
Other		-0.2		-0.1		-4		-		-4.3
Net cash provided by (used in) financing activities		19.3		33.7		-31.5		-		21.5
Change in cash and cash equivalents		-		80.2		9.8		-		90.0
Cash and cash equivalents at beginning of period		-		25.0		60.0		-		85.0
Cash and cash equivalents at end of period	$	-	$	105.2	$	69.8	$	-	$	175.0

Revenue_Recognition_And_Accoun1

Revenue Recognition And Accounts Receivable (Tables)	6 Months Ended
	Jun. 30, 2014
Revenue Recognition And Accounts Receivable [Abstract]	'
Schedule Of Revenues By Payor And Approximate Percentages Of Revenues	'
		Three Months Ended June 30,								Six Months Ended June 30,
		2014				2013				2014				2013
				% of				% of				% of				% of
		Amount		Revenues		Amount		Revenues		Amount		Revenues		Amount		Revenues
	Medicare	$	325.0	31.0	%	$	289.4	32.3	%	$	641.8	31.2	%	$	607.6	33.3	%
	Medicaid		149.8	14.3			124.4	13.9			290.0	14.1			251.2	13.8
	HMOs, PPOs and other private insurers		577.6	55.1			466.6	52.2			1,114.2	54.3			924.2	50.6
	Self-pay		172.3	16.5			176.5	19.7			339.5	16.5			357.9	19.6
	Other		21.5	2.1			18.8	2.1			43.5	2.1			35.0	1.9
	Revenues before provision for
	doubtful accounts		1,246.2	119.0			1,075.7	120.2			2,429.0	118.2			2,175.9	119.2
	Provision for doubtful accounts		-199.2	-19			-180.8	-20.2			-374.8	-18.2			-349.9	-19.2
	Revenues	$	1,047.0	100.0	%	$	894.9	100.0	%	$	2,054.2	100.0	%	$	1,826.0	100.0	%
Schedule Of Allowance For Doubtful Accounts	'
	Balance at January 1, 2014	$	741.2
	Additions recognized as a reduction to revenues		374.8
	Accounts written off, net of recoveries		-352.1
	Balance at June 30, 2014	$	763.9

Fair_Value_Of_Financial_Instru1

Fair Value Of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2014
Fair Value Of Financial Instruments [Abstract]	'
Schedule Of Carrying Amount And Fair Value	'
		Carrying Amount				Fair Value
		June 30,		December 31,		June 30,		December 31,
		2014		2013		2014		2013
	Senior Credit Agreement:
	Term Facility	$	427.5	$	433.1	$	427.0	$	434.2
	Incremental Term Loans, excluding unamortized discount	$	222.6	$	222.6	$	222.8	$	224.2
	6.625% Senior Notes	$	400.0	$	400.0	$	431.0	$	425.0
	5.5% Senior Notes, excluding unamortized premium	$	1,100.0	$	700.0	$	1,153.6	$	703.5
	3 ½ %  Notes, excluding unamortized discount	$	-	$	575.0	$	-	$	622.4

Goodwill_And_Intangible_Assets1

Goodwill And Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2014
Goodwill And Intangible Assets [Abstract]	'
Schedule of Intangible Assets	'
		June 30,		December 31,
		2014		2013
	Amortized intangible assets:
	Contract-based physician minimum revenue guarantees
	Gross carrying amount	$	67.8	$	73.4
	Accumulated amortization		-37.3		-39.4
	Net total		30.5		34.0
	Non-competition agreements
	Gross carrying amount		24.5		24.5
	Accumulated amortization		-15.6		-14.1
	Net total		8.9		10.4
	Total amortized intangible assets
	Gross carrying amount		92.3		97.9
	Accumulated amortization		-52.9		-53.5
	Net total		39.4		44.4
	Indefinite-lived intangible assets:
	Certificates of need and certificates of need exemptions		27.9		24.9
	Licenses, provider numbers, accreditations and other		4.1		3.3
	Net total		32.0		28.2
	Total intangible assets:
	Gross carrying amount		124.3		126.1
	Accumulated amortization		-52.9		-53.5
	Net total	$	71.4	$	72.6

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2014
Stock-Based Compensation [Abstract]	'
Schedule Of Estimates Of Weighted-Average Fair Value Per Share Of Stock Options Granted	'
		Six Months Ended June 30,
		2014				2013
	Expected volatility		29.0	%			31.0	%
	Risk-free interest rate, minimum		0.05	%			0.05	%
	Risk-free interest rate, maximum		2.71	%			1.95	%
	Expected dividends		-				-
	Average expected term (years)		5.4				5.3
	Fair value per share of stock options granted	$	13.95			$	11.97
Schedule Of Total Stock-Based Compensation Expense And Total Recognized Tax Benefits	'
		Three Months Ended						Six Months Ended
		June 30,						June 30,
		2014			2013			2014		2013
	Equity awards:
	Other stock-based awards	$	4.2		$	4.2		$	8.5	$	8.2
	Stock options		2.2			2.1			4.6		4.9
			6.4			6.3			13.1		13.1
	Liability awards:
	Other stock-based awards		0.5			-			0.7		-
	Total stock-based compensation expense	$	6.9		$	6.3		$	13.8	$	13.1
	Tax benefit on stock-based compensation expense	$	2.7		$	2.5		$	5.5	$	5.3

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Computation Of Basic And Diluted Earnings (Loss) Per Share	'
		Three Months Ended				Six Months Ended
		June 30,				June 30,
		2014		2013		2014		2013
	Numerator for basic and diluted earnings per share
	attributable to LifePoint Hospitals, Inc.:
	Income from continuing operations	$	41.8	$	27.2	$	79.5	$	60.2
	Less: Net income attributable to noncontrolling interests
	and redeemable noncontrolling interests		-2.7		-0.1		-3.3		-0.8
	Income from continuing operations attributable to
	LifePoint Hospitals, Inc. stockholders		39.1		27.1		76.2		59.4
	Income from discontinued operations, net of income taxes		-		0.3		-		0.4
	Net income attributable to LifePoint Hospitals, Inc.	$	39.1	$	27.4	$	76.2	$	59.8
	Denominator:
	Weighted average shares outstanding - basic		44.5		46.5		45.2		46.2
	Effect of dilutive securities:
	Stock options and other stock-based awards		1.7		1.2		1.6		1.3
	Convertible debt instruments		0.3		-		0.5		-
	Weighted average shares outstanding - diluted		46.5		47.7		47.3		47.5
	Basic earnings per share attributable to LifePoint Hospitals,
	Inc. stockholders:
	Continuing operations	$	0.88	$	0.58	$	1.69	$	1.29
	Discontinued operations		-		0.01		-		0.01
	Net income	$	0.88	$	0.59	$	1.69	$	1.30
	Diluted earnings per share attributable to LifePoint Hospitals,
	Inc. stockholders:
	Continuing operations	$	0.84	$	0.57	$	1.61	$	1.25
	Discontinued operations		-		-		-		0.01
	Net income	$	0.84	$	0.57	$	1.61	$	1.26

Guarantor_And_NonGuarantor_Sup1

Guarantor And Non-Guarantor Supplementary Information (Tables)	6 Months Ended
	Jun. 30, 2014
Guarantor And Non-Guarantor Supplementary Information [Abstract]	'
Schedule Of Condensed Consolidating Statements Of Operations	'
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended June 30, 2014
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	861.8	$	384.4	$	-	$	1,246.2
	Provision for doubtful accounts		-		140.4		58.8		-		199.2
	Revenues		-		721.4		325.6		-		1,047.0
	Salaries and benefits		6.9		323.5		158.1		-		488.5
	Supplies		-		104.4		58.1		-		162.5
	Other operating expenses		-		187.2		71.1		-		258.3
	Other income		-		-15.2		-5.8		-		-21
	Equity in earnings of affiliates		-57.6		-		-		57.6		-
	Depreciation and amortization		-		46.1		14.8		-		60.9
	Interest expense, net		11.8		17.7		1.8		-		31.3
	Management (income) fees		-		-4.9		4.9		-		-
			-38.9		658.8		303.0		57.6		980.5
	Income from continuing operations
	before taxes		38.9		62.6		22.6		-57.6		66.5
	(Benefit) provision for income taxes		-0.2		24.9		-		-		24.7
	Net income		39.1		37.7		22.6		-57.6		41.8
	Less:  Net income attributable to
	noncontrolling interests and
	redeemable noncontrolling interests		-		-0.2		-2.5		-		-2.7
	Net income attributable to LifePoint
	Hospitals, Inc.	$	39.1	$	37.5	$	20.1	$	-57.6	$	39.1
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
	For the Three Months Ended June 30, 2013
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Revenues before provision for
	doubtful accounts	$	-	$	815.6	$	260.1	$	-	$	1,075.7
	Provision for doubtful accounts		-		141.5		39.3		-		180.8
	Revenues		-		674.1		220.8		-		894.9
	Salaries and benefits		6.3		312.1		103.7		-		422.1
	Supplies		-		102.3		41.8		-		144.1
	Other operating expenses		0.1		171.5		51.3		-		222.9
	Other income		-		-9.9		-1.1		-		-11
	Equity in earnings of affiliates		-38		-		-		38.0		-
	Depreciation and amortization		-		43.4		12.5		-		55.9
	Interest expense, net		3.3		17.1		2.2		-		22.6
	Gain on settlement of pre-acquisition
	contingent obligation		-		-		-5.6		-		-5.6
	Management (income) fees		-		-3.2		3.2		-		-
			-28.3		633.3		208.0		38.0		851.0
	Income from continuing operations
	before taxes		28.3		40.8		12.8		-38		43.9
	Provision for income taxes		0.9		15.8		-		-		16.7
	Income from continuing operations		27.4		25.0		12.8		-38		27.2
	Income from discontinued operations,
	net of taxes		-		0.3		-		-		0.3
	Net income		27.4		25.3		12.8		-38		27.5
	Less:  Net (income) loss attributable
	to noncontrolling interests and
	redeemable noncontrolling interests		-		-0.3		0.2		-		-0.1
	Net income attributable to LifePoint
	Hospitals, Inc.	$	27.4	$	25.0	$	13.0	$	-38	$	27.4
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Operations
For the Six Months Ended June 30, 2014
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Revenues before provision for
doubtful accounts	$	-	$	1,699.8	$	729.2	$	-	$	2,429.0
Provision for doubtful accounts		-		268.7		106.1		-		374.8
Revenues		-		1,431.1		623.1		-		2,054.2
Salaries and benefits		13.8		648.0		301.5		-		963.3
Supplies		-		207.1		112.4		-		319.5
Other operating expenses		-		367.9		133.9		-		501.8
Other income		-		-28.8		-6.1		-		-34.9
Equity in earnings of affiliates		-113.9		-		-		113.9		-
Depreciation and amortization		-		91.4		30.6		-		122.0
Interest expense, net		26.1		34.7		4.4		-		65.2
Management (income) fees		-		-10		10.0		-		-
		-74		1,310.3		586.7		113.9		1,936.9
Income from continuing operations
before taxes		74.0		120.8		36.4		-113.9		117.3
(Benefit) provision for income taxes		-2.2		40.0		-		-		37.8
Net income		76.2		80.8		36.4		-113.9		79.5
Less:  Net income attributable to
noncontrolling interests and
redeemable noncontrolling interests		-		-0.4		-2.9		-		-3.3
Net income attributable to LifePoint
Hospitals, Inc.	$	76.2	$	80.4	$	33.5	$	-113.9	$	76.2
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Operations
For the Six Months Ended June 30, 2013
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Revenues before provision for
doubtful accounts	$	-	$	1,658.4	$	517.5	$	-	$	2,175.9
Provision for doubtful accounts		-		275.7		74.2		-		349.9
Revenues		-		1,382.7		443.3		-		1,826.0
Salaries and benefits		13.1		631.8		210.4		-		855.3
Supplies		-		202.9		85.9		-		288.8
Other operating expenses		0.5		345.7		98.2		-		444.4
Other income		-		-15.6		-1.1		-		-16.7
Equity in earnings of affiliates		-82.9		-		-		82.9		-
Depreciation and amortization		-		87.0		24.7		-		111.7
Interest expense, net		8.1		34.0		4.4		-		46.5
Gain on settlement of pre-acquisition
contingent obligation		-		-		-5.6		-		-5.6
Debt transaction costs		4.4		-		-		-		4.4
Management (income) fees		-		-6.5		6.5		-		-
		-56.8		1,279.3		423.4		82.9		1,728.8
Income from continuing operations
before taxes		56.8		103.4		19.9		-82.9		97.2
(Benefit) provision for income taxes		-3		40.0		-		-		37.0
Income from continuing operations		59.8		63.4		19.9		-82.9		60.2
Income from discontinued operations,
net of taxes		-		0.4		-		-		0.4
Net income		59.8		63.8		19.9		-82.9		60.6
Less:  Net income attributable to
noncontrolling interests and
redeemable noncontrolling interests		-		-0.3		-0.5		-		-0.8
Net income attributable to LifePoint
Hospitals, Inc.	$	59.8	$	63.5	$	19.4	$	-82.9	$	59.8
Schedule Of Condensed Consolidating Balance Sheets	'
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Balance Sheets
	30-Jun-14
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	ASSETS
	Current assets:
	Cash and cash equivalents	$	-	$	234.9	$	107.1	$	-	$	342.0
	Accounts receivable, net		-		472.0		174.4		-		646.4
	Inventories		-		73.0		33.9		-		106.9
	Prepaid expenses		0.3		29.1		9.3		-		38.7
	Deferred tax assets		130.1		-		-		-		130.1
	Other current assets		16.8		50.9		38.8		-		106.5
			147.2		859.9		363.5		-		1,370.6
	Property and equipment:
	Land		-		73.8		55.6		-		129.4
	Buildings and improvements		-		1,578.2		487.5		-		2,065.7
	Equipment		-		1,271.7		254.1		-		1,525.8
	Construction in progress		-		41.3		18.8		-		60.1
			-		2,965.0		816.0		-		3,781.0
	Accumulated depreciation		-		-1,380.40		-183.2		-		-1,563.60
			-		1,584.6		632.8		-		2,217.4
	Deferred loan costs, net		33.5		-		-		-		33.5
	Intangible assets, net		-		37.3		34.1		-		71.4
	Investments in subsidiaries		1,959.4		-		-		-1,959.40		-
	Due from subsidiaries		2,399.8		-		-		-2,399.80		-
	Other		4.7		19.3		14.5		-		38.5
	Goodwill		-		1,435.4		194.7		-		1,630.1
	Total assets	$	4,544.6	$	3,936.5	$	1,239.6	$	-4,359.20	$	5,361.5
	LIABILITIES AND EQUITY
	Current liabilities:
	Accounts payable	$	-	$	101.0	$	47.1	$	-	$	148.1
	Accrued salaries		-		102.6		44.0		-		146.6
	Other current liabilities		12.9		122.0		50.5		-		185.4
	Current maturities of long-term debt		11.3		0.6		1.0		-		12.9
			24.2		326.2		142.6		-		493.0
	Long-term debt		2,149.4		49.5		3.6		-		2,202.5
	Due to Parent		-		1,914.4		485.4		-2,399.80		-
	Deferred income tax liabilities		203.8		-		-		-		203.8
	Long-term portion of reserves for self-insurance claims		-		104.8		29.1		-		133.9
	Other long-term liabilities		-		20.6		35.7		-		56.3
	Long-term income tax liability		18.9		-		-		-		18.9
	Total liabilities		2,396.3		2,415.5		696.4		-2,399.80		3,108.4
	Redeemable noncontrolling interests		-		-		84.7		-		84.7
	Total LifePoint Hospitals, Inc. stockholders' equity		2,148.3		1,519.7		439.7		-1,959.40		2,148.3
	Noncontrolling interests		-		1.3		18.8		-		20.1
	Total equity		2,148.3		1,521.0		458.5		-1,959.40		2,168.4
	Total liabilities and equity	$	4,544.6	$	3,936.5	$	1,239.6	$	-4,359.20	$	5,361.5
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Balance Sheets
	December 31, 2013
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	ASSETS
	Current assets:
	Cash and cash equivalents	$	-	$	558.3	$	79.6	$	-	$	637.9
	Accounts receivable, net		-		444.3		151.4		-		595.7
	Inventories		-		73.4		28.6		-		102.0
	Prepaid expenses		0.1		30.6		7.3		-		38.0
	Deferred tax assets		147.7		-		-		-		147.7
	Other current assets		-		53.0		19.9		-		72.9
		147.8		1,159.6		286.8		-		1,594.2
Property and equipment:
Land		-		76.0		36.3		-		112.3
Buildings and improvements		-		1,570.1		449.5		-		2,019.6
Equipment		-		1,256.4		213.5		-		1,469.9
Construction in progress		-		45.6		13.1		-		58.7
		-		2,948.1		712.4		-		3,660.5
Accumulated depreciation		-		-1,309.00		-154.3		-		-1,463.30
		-		1,639.1		558.1		-		2,197.2
Deferred loan costs, net		31.1		-		-		-		31.1
Intangible assets, net		-		40.3		32.3		-		72.6
Investments in subsidiaries		1,853.1		-		-		-1,853.10		-
Due from subsidiaries		2,760.4		-		-		-2,760.40		-
Other		3.4		22.4		14.9		-		40.7
Goodwill		-		1,435.1		215.9		-		1,651.0
Total assets	$	4,795.8	$	4,296.5	$	1,108.0	$	-4,613.50	$	5,586.8
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	-	$	99.1	$	36.8	$	-	$	135.9
Accrued salaries		-		102.1		37.5		-		139.6
Other current liabilities		14.8		146.4		36.0		-		197.2
Current maturities of long-term debt		581.4		0.7		0.9		-		583.0
		596.2		348.3		111.2		-		1,055.7
Long-term debt		1,739.8		50.0		4.0		-		1,793.8
Due to Parent		-		2,324.8		435.6		-2,760.40		-
Deferred income tax liabilities		233.1		-		-		-		233.1
Long-term portion of reserves for self-insurance claims		-		113.5		26.3		-		139.8
Other long-term liabilities		-		20.2		35.2		-		55.4
Long-term income tax liability		16.6		-		-		-		16.6
Total liabilities		2,585.7		2,856.8		612.3		-2,760.40		3,294.4
Redeemable noncontrolling interests		-		-		59.8		-		59.8
Total LifePoint Hospitals, Inc. stockholders' equity		2,210.1		1,438.2		414.9		-1,853.10		2,210.1
Noncontrolling interests		-		1.5		21.0		-		22.5
Total equity		2,210.1		1,439.7		435.9		-1,853.10		2,232.6
Total liabilities and equity	$	4,795.8	$	4,296.5	$	1,108.0	$	-4,613.50	$	5,586.8
Schedule Of Condensed Consolidating Statements Of Cash Flows	'
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Cash Flows
	For the Three Months Ended June 30, 2014
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Cash flows from operating activities:
	Net income	$	39.1	$	37.7	$	22.6	$	-57.6	$	41.8
	Adjustments to reconcile net income to net cash provided
	by operating activities:
	Equity in earnings of affiliates		-57.6		-		-		57.6		-
	Stock-based compensation		6.4		-		-		-		6.4
	Depreciation and amortization		-		46.1		14.8		-		60.9
	Amortization of physician minimum revenue guarantees		-		3.3		0.5		-		3.8
	Amortization of debt discounts, premium and deferred loan costs		4.3		-		-		-		4.3
	Deferred income taxes		36.5		-		-		-		36.5
	Reserve for self-insurance claims, net of payments		-		-1.4		-		-		-1.4
	Increase (decrease) in cash from operating assets and
	liabilities, net of effects of acquisitions and divestitures:
	Accounts receivable		-		2.9		19.3		-		22.2
	Inventories and other current assets		-0.3		-5.2		2.8		-		-2.7
	Accounts payable and accrued expenses		-21		-16.6		6.3		-		-31.3
	Income taxes payable/receivable		-71.8		-		-		-		-71.8
	Other		-		0.2		-0.9		-		-0.7
	Net cash (used in) provided by operating activities		-64.4		67.0		65.4		-		68.0
	Cash flows from investing activities:
	Purchases of property and equipment		-		-21.6		-9.6		-		-31.2
	Acquisitions, net of cash acquired		-		-		-27.2		-		-27.2
	Other		-0.4		1.0		-0.5		-		0.1
	Net cash used in investing activities		-0.4		-20.6		-37.3		-		-58.3
	Cash flows from financing activities:
	Proceeds from borrowings		412.0		-		-		-		412.0
	Payments of borrowings		-579.8		-		-		-		-579.8
	Repurchases of common stock		-36.1		-		-		-		-36.1
	Payment of debt financing costs		-5.5		-		-		-		-5.5
	Proceeds from exercise of stock options		11.1		-		-		-		11.1
	Change in intercompany balances with affiliates, net		263.2		-253.2		-10		-		-
	Other		-0.1		-0.1		-1.5		-		-1.7
	Net cash provided by (used in) financing activities		64.8		-253.3		-11.5		-		-200
	Change in cash and cash equivalents		-		-206.9		16.6		-		-190.3
	Cash and cash equivalents at beginning of period		-		441.8		90.5		-		532.3
	Cash and cash equivalents at end of period	$	-	$	234.9	$	107.1	$	-	$	342.0
	LIFEPOINT HOSPITALS, INC.
	Condensed Consolidating Statements of Cash Flows
	For the Three Months Ended June 30, 2013
	(In millions)
		Parent				Non-
		Issuer		Guarantors		Guarantors		Eliminations		Consolidated
	Cash flows from operating activities:
	Net income	$	27.4	$	25.3	$	12.8	$	-38	$	27.5
	Adjustments to reconcile net income to net cash provided
	by operating activities:
	Income from discontinued operations		-		-0.3		-		-		-0.3
	Equity in earnings of affiliates		-38		-		-		38.0		-
	Stock-based compensation		6.3		-		-		-		6.3
	Depreciation and amortization		-		43.4		12.5		-		55.9
	Amortization of physician minimum revenue guarantees		-		4.2		0.3		-		4.5
	Amortization of debt discounts and deferred loan costs		6.0		-		-		-		6.0
	Gain on settlement of contingent obligation		-		-		-5.6		-		-5.6
	Deferred income tax benefit		-36.6		-		-		-		-36.6
	Reserve for self-insurance claims, net of payments		-		0.2		1.9		-		2.1
	Increase (decrease) in cash from operating assets and
	liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		1.0		9.9		-		10.9
Inventories and other current assets		-0.1		12.2		-1.2		-		10.9
Accounts payable and accrued expenses		-11.8		-8.1		4.1		-		-15.8
Income taxes payable/receivable		-7.5		-		-		-		-7.5
Other		-0.1		-0.5		-0.2		-		-0.8
Net cash (used in) provided by operating activities - continuing
operations		-54.4		77.4		34.5		-		57.5
Net cash used in operating activities - discontinued operations		-		-0.6		-		-		-0.6
Net cash (used in) provided by operating activities		-54.4		76.8		34.5		-		56.9
Cash flows from investing activities:
Purchases of property and equipment		-		-28.5		-8.8		-		-37.3
Acquisitions, net of cash acquired		-		-4.9		-		-		-4.9
Other		-		0.2		1.0		-		1.2
Net cash used in investing activities		-		-33.2		-7.8		-		-41
Cash flows from financing activities:
Payments of borrowings		-3.6		-		-		-		-3.6
Repurchases of common stock		-0.1		-		-		-		-0.1
Payment of debt financing costs		-0.1		-						-0.1
Proceeds from exercise of stock options		4.6		-		-		-		4.6
Change in intercompany balances with affiliates, net		53.8		-28.5		-25.3		-		-
Other		-0.2		0.1		-2		-		-2.1
Net cash provided by (used in) financing activities		54.4		-28.4		-27.3		-		-1.3
Change in cash and cash equivalents		-		15.2		-0.6		-		14.6
Cash and cash equivalents at beginning of period		-		90.0		70.4		-		160.4
Cash and cash equivalents at end of period	$	-	$	105.2	$	69.8	$	-	$	175.0
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Six Months Ended June 30, 2014
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	76.2	$	80.8	$	36.4	$	-113.9	$	79.5
Adjustments to reconcile net income to net cash provided
by operating activities:
Equity in earnings of affiliates		-113.9		-		-		113.9		-
Stock-based compensation		13.1		-		-		-		13.1
Depreciation and amortization		-		91.4		30.6		-		122.0
Amortization of physician minimum revenue guarantees		-		6.9		0.8		-		7.7
Amortization of debt discounts, premium and deferred loan costs		11.6		-		-		-		11.6
Deferred income tax benefit		-5.1		-		-		-		-5.1
Reserve for self-insurance claims, net of payments		-		1.9		2.8		-		4.7
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		-29.3		1.0		-		-28.3
Inventories and other current assets		-0.2		18.6		2.0		-		20.4
Accounts payable and accrued expenses		0.7		-45.1		12.8		-		-31.6
Income taxes payable/receivable		-19.3		-		-		-		-19.3
Other		-0.1		1.5		0.5		-		1.9
Net cash (used in) provided by operating activities		-37		126.7		86.9		-		176.6
Cash flows from investing activities:
Purchases of property and equipment		-		-37.3		-16.4		-		-53.7
Acquisitions, net of cash acquired		-		-2.7		-85.1		-		-87.8
Other		-1.2		0.4		0.4		-		-0.4
Net cash used in investing activities		-1.2		-39.6		-101.1		-		-141.9
Cash flows from financing activities:
Proceeds from borrowings		412.0		-		-		-		412.0
Payments of borrowings		-579.8		-		-		-		-579.8
Repurchases of common stock		-171.9		-		-		-		-171.9
Payment of debt financing costs		-5.9		-		-		-		-5.9
Proceeds from exercise of stock options		18.3		-		-		-		18.3
Change in intercompany balances with affiliates, net		365.6		-410.4		44.8		-		-
Other		-0.1		-0.1		-3.1		-		-3.3
Net cash provided by (used in) financing activities		38.2		-410.5		41.7		-		-330.6
Change in cash and cash equivalents		-		-323.4		27.5		-		-295.9
Cash and cash equivalents at beginning of period		-		558.3		79.6		-		637.9
Cash and cash equivalents at end of period	$	-	$	234.9	$	107.1	$	-	$	342.0
LIFEPOINT HOSPITALS, INC.
Condensed Consolidating Statements of Cash Flows
For the Six Months Ended June 30, 2013
(In millions)
	Parent				Non-
	Issuer		Guarantors		Guarantors		Eliminations		Consolidated
Cash flows from operating activities:
Net income	$	59.8	$	63.8	$	19.9	$	-82.9	$	60.6
Adjustments to reconcile net income to net cash provided
by operating activities:
Income from discontinued operations		-		-0.4		-		-		-0.4
Equity in earnings of affiliates		-82.9		-		-		82.9		-
Stock-based compensation		13.1		-		-		-		13.1
Depreciation and amortization		-		87.0		24.7		-		111.7
Amortization of physician minimum revenue guarantees		-		8.2		0.8		-		9.0
Amortization of debt discounts and deferred loan costs		13.1		-		-		-		13.1
Gain on settlement of pre-acquisition contingent obligation		-		-		-5.6		-		-5.6
Debt transaction costs		4.4		-		-		-		4.4
Deferred income tax benefit		-43.7		-		-		-		-43.7
Reserve for self-insurance claims, net of payments		-		0.6		6.1		-		6.7
Increase (decrease) in cash from operating assets and
liabilities, net of effects of acquisitions and divestitures:
Accounts receivable		-		-23.6		5.0		-		-18.6
Inventories and other current assets		-		6.4		-1.6		-		4.8
Accounts payable and accrued expenses		-2.4		-31.8		8.2		-		-26
Income taxes payable/receivable		19.5		-		-		-		19.5
Other		-		0.4		0.3		-		0.7
Net cash (used in) provided by operating activities - continuing
operations		-19.1		110.6		57.8		-		149.3
Net cash used in operating activities - discontinued operations		-		-0.2		-		-		-0.2
Net cash (used in) provided by operating activities		-19.1		110.4		57.8		-		149.1
Cash flows from investing activities:
Purchases of property and equipment		-		-58.3		-17.5		-		-75.8
Acquisitions, net of cash acquired		-		-6.2		-		-		-6.2
Other		-0.2		0.6		1.0		-		1.4
Net cash used in investing activities		-0.2		-63.9		-16.5		-		-80.6
Cash flows from financing activities:
Proceeds from borrowings		323.0		-		-		-		323.0
Payments of borrowings		-317.2		-		-		-		-317.2
Repurchases of common stock		-7.2		-		-		-		-7.2
Payment of debt financing costs		-1		-		-		-		-1
Proceeds from exercise of stock options		28.2		-		-		-		28.2
Change in intercompany balances with affiliates, net		-6.3		33.8		-27.5		-		-
Other		-0.2		-0.1		-4		-		-4.3
Net cash provided by (used in) financing activities		19.3		33.7		-31.5		-		21.5
Change in cash and cash equivalents		-		80.2		9.8		-		90.0
Cash and cash equivalents at beginning of period		-		25.0		60.0		-		85.0
Cash and cash equivalents at end of period	$	-	$	105.2	$	69.8	$	-	$	175.0

Organization_Basis_Of_Presenta1

Organization, Basis Of Presentation And Recently Issued Accounting Pronouncment (Details)	Jun. 30, 2014
	state
	site
Organization, Basis Of Presentation And Recently Issued Accounting Pronouncement [Abstract]	'
Number of hospital campuses operated by company	62
Number of states in which the company operates	20

Recovered_Sheet1

Revenue Recognition and Accounts Receivable (Schedule Of Revenues By Payor And Approximate Percentages Of Revenues) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Health Care Organization, Receivable and Revenue Disclosures [Line Items]	'	'	'	'
Ratio of Revenues before provision for doubtful accounts	119.00%	120.20%	118.20%	119.20%
Ratio of Provision for doubtful accounts	-19.00%	-20.20%	-18.20%	-19.20%
Ratio of Net Revenues	100.00%	100.00%	100.00%	100.00%
Revenues before provision for doubtful accounts	$1,246.20	$1,075.70	$2,429	$2,175.90
Provision for doubtful accounts	-199.2	-180.8	-374.8	-349.9
Revenues	1,047	894.9	2,054.20	1,826
Medicare [Member]	'	'	'	'
Health Care Organization, Receivable and Revenue Disclosures [Line Items]	'	'	'	'
Ratio of Revenues before provision for doubtful accounts	31.00%	32.30%	31.20%	33.30%
Revenues before provision for doubtful accounts	325	289.4	641.8	607.6
Medicaid [Member]	'	'	'	'
Health Care Organization, Receivable and Revenue Disclosures [Line Items]	'	'	'	'
Ratio of Revenues before provision for doubtful accounts	14.30%	13.90%	14.10%	13.80%
Revenues before provision for doubtful accounts	149.8	124.4	290	251.2
HMOs, PPOs And Other Private Insurers [Member]	'	'	'	'
Health Care Organization, Receivable and Revenue Disclosures [Line Items]	'	'	'	'
Ratio of Revenues before provision for doubtful accounts	55.10%	52.20%	54.30%	50.60%
Revenues before provision for doubtful accounts	577.6	466.6	1,114.20	924.2
Self-pay [Member]	'	'	'	'
Health Care Organization, Receivable and Revenue Disclosures [Line Items]	'	'	'	'
Ratio of Revenues before provision for doubtful accounts	16.50%	19.70%	16.50%	19.60%
Revenues before provision for doubtful accounts	172.3	176.5	339.5	357.9
Other Payors [Member]	'	'	'	'
Health Care Organization, Receivable and Revenue Disclosures [Line Items]	'	'	'	'
Ratio of Revenues before provision for doubtful accounts	2.10%	2.10%	2.10%	1.90%
Revenues before provision for doubtful accounts	$21.50	$18.80	$43.50	$35

Revenue_Recognition_And_Accoun2

Revenue Recognition And Accounts Receivable (Schedule Of Allowance For Doubtful Accounts) (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Revenue Recognition And Accounts Receivable [Abstract]	'	'	'	'	'	'
Balances at Beginning of Year	'	'	$741.20	'	'	'
Provision for doubtful accounts	199.2	180.8	374.8	349.9	'	'
Accounts written off, net of recoveries	'	'	-352.1	'	'	'
Balances at End of Year	$763.90	'	$763.90	'	$741.20	'
Percent of gross accounts receivable for doubtful accounts	'	'	54.20%	'	55.40%	'
Percent of self-pay receivables for allowance for doubtful accounts	'	'	87.80%	'	86.50%	86.50%

General_And_Administrative_Cos1

General And Administrative Costs (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
General And Administrative Costs [Abstract]	'	'	'	'
General and administrative included in corporate overhead costs	$53.90	$43	$106.10	$91

Fair_Value_Of_Financial_Instru2

Fair Value Of Financial Instruments (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Term Facility [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Carrying Amount	$427.50	$433.10
Fair Value	427	434.2
Incremental Term Loans [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Carrying Amount	222.6	222.6
Fair Value	222.8	224.2
6.625% Senior Notes [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Carrying Amount	400	400
Fair Value	431	425
Debt instrument stated interest rate	6.63%	'
Debt instrument, maturity date	1-Oct-20	'
5.5% Senior Notes [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Carrying Amount	1,100	700
Fair Value	1,153.60	703.5
Debt instrument stated interest rate	5.50%	'
Debt instrument, maturity date	1-Dec-21	'
Debt Instrument, Issuance Date	12-May-14	'
Debt Instrument, Face Amount	400	'
Proceeds from issuance of senior long-term debt	412	'
Debt Instrument, Unamortized Premium	12	'
3.5% Notes [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Carrying Amount	'	575
Fair Value	'	$622.40
Debt instrument stated interest rate	3.50%	'
Debt instrument, maturity date	15-May-14	'

Acquisitions_Details

Acquisitions (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
	item
Rutherford [Member]	'
Business Acquisition [Line Items]	'
Acquisition date	1-Jun-14
Percentage of interest acquired	80.00%
Cost of business acquisition	$27.20
Number of beds in hospital	143
Amounts committed to invest in capital expenditures and improvements subsequent to acquisition	60
Term for committed investment in capital expenditure and improvements, in years	'10 years
Wilson [Member]	'
Business Acquisition [Line Items]	'
Acquisition date	1-Mar-14
Percentage of interest acquired	80.00%
Cost of business acquisition	59.8
Number of beds in hospital	294
Number of beds in long-term care facility	90
Amounts committed to invest in capital expenditures and improvements subsequent to acquisition	$120
Term for committed investment in capital expenditure and improvements, in years	'10 years

Goodwill_And_Intangible_Assets2

Goodwill And Intangible Assets (Narrative) (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Goodwill And Intangible Assets [Line Items]	'	'
Other current liabilities	$185.40	$197.20
Parent Issuer [Member]	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Other current liabilities	12.9	14.8
Physician Minimum Revenue Guarantees Liability [Member]	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Other current liabilities	$10.50	$11.50

Goodwill_And_Intangible_Assets3

Goodwill And Intangible Assets (Summary Of Intangible Assets) (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Goodwill And Intangible Assets [Line Items]	'	'
Gross carrying amount	$124.30	$126.10
Accumulated amortization	-52.9	-53.5
Net total	71.4	72.6
Indefinite-lived intangible assets	32	28.2
Physician Minimum Revenue Guarantees Liability [Member]	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Gross Carrying Amount	67.8	73.4
Accumulated amortization	-37.3	-39.4
Net total	30.5	34
Non-Competition Agreements [Member]	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Gross Carrying Amount	24.5	24.5
Accumulated amortization	-15.6	-14.1
Net total	8.9	10.4
Total Amortized Intangible Assets [Member]	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Gross Carrying Amount	92.3	97.9
Accumulated amortization	-52.9	-53.5
Net total	39.4	44.4
Licenses, Provider Numbers, Accreditations And Other [Member]	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Indefinite-lived intangible assets	4.1	3.3
Certificates Of Need And Certificates Of Need Exemptions [Member]	'	'
Goodwill And Intangible Assets [Line Items]	'	'
Indefinite-lived intangible assets	$27.90	$24.90

LongTerm_Debt_Narrative_Detail

Long-Term Debt (Narrative) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Debt Instrument [Line Items]	'	'	'	'
Costs related to the debt issuance	$5.50	$0.10	$5.90	$1
Conversion of 3 1/2 % Notes, shares	'	'	0.6	'
Average purchase price per share for shares repurchased	'	'	$35.86	'
Conversion of 3 1/2 % Notes, treasury stock reissued	'	'	23	'
Debt transaction costs	'	'	'	4.4
6.625% Senior Notes [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Debt instrument, maturity date	'	'	1-Oct-20	'
Debt instrument stated interest rate	6.63%	'	6.63%	'
5.5% Senior Notes [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Debt Instrument, Issuance Date	'	'	12-May-14	'
Debt Instrument, Face Amount	400	'	400	'
Debt instrument, maturity date	'	'	1-Dec-21	'
Proceeds from issuance of senior long-term debt	'	'	412	'
Debt instrument stated interest rate	5.50%	'	5.50%	'
Debt instrument effective interest rate	4.90%	'	4.90%	'
Debt Instrument, Unamortized Premium	12	'	12	'
Costs related to the debt issuance	'	'	5.5	'
Aggregate principal amounts	400	'	400	'
Effective interest rates	4.90%	'	4.90%	'
3.5% Notes [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Debt instrument, maturity date	'	'	15-May-14	'
Debt instrument stated interest rate	3.50%	'	3.50%	'
Repayments of debt	'	'	$574.20	'

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Accounting For Income Taxes [Line Items]	'	'	'	'
Provision for income taxes	$24.70	$16.70	$37.80	$37
Effective Income Tax Rate, Continuing Operations	'	'	33.20%	38.40%
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability	'	'	6	'
EPS Impact of Valuation Allowance Adjustment	'	'	$0.13	'
Parent Issuer [Member]	'	'	'	'
Accounting For Income Taxes [Line Items]	'	'	'	'
Provision for income taxes	($0.20)	$0.90	($2.20)	($3)

Common_Stock_In_Treasury_Narra

Common Stock In Treasury (Narrative) (Details) (USD $)	3 Months Ended	6 Months Ended
In Millions, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2013
Common Stock In Treasury And Repurchases Of Common Stock [Line Items]	'	'	'
Share Repurchased, Amount	'	$171.90	'
Average purchase price per share for shares repurchased	'	$35.86	'
Vested shares redeemed under LTIP and MSPP	'	100,000	200,000
Aggregate price of vested shares redeemed under LTIP and MSPP	'	7.2	7.2
Conversion of 3 1/2 % Notes, shares	'	600,000	'
Conversion of 3 1/2 % Notes, treasury stock reissued	'	23	'
2011 Repurchase Plan [Member]	'	'	'
Common Stock In Treasury And Repurchases Of Common Stock [Line Items]	'	'	'
Board of Directors authorized the shares repurchase	'	350	'
Total number of shares repurchased	600,000	3,000,000	0
Share Repurchased, Amount	36.1	164.7	'
Average purchase price per share for shares repurchased	$58.69	$54.33	'
2014 Repurchase Plan [Member]	'	'	'
Common Stock In Treasury And Repurchases Of Common Stock [Line Items]	'	'	'
Board of Directors authorized the shares repurchase	'	150	'
Remaining amount authorized to repurchase	'	$150	'

StockBased_Compensation_Narrat

Stock-Based Compensation (Narrative) (Details) (USD $)

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

In Millions, except Share data, unless otherwise specified

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Mar. 31, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Restricted Stock Units (RSUs) [Member]

Performance Shares [Member]

Performance Shares [Member]

2013 Long-Term Incentive Plan [Member]

2013 Long-Term Incentive Plan [Member]

2013 Long-Term Incentive Plan [Member]

1998 Long-Term Incentive Plan [Member]

2013 Long Term Incentive Plan BOD Awards [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

LTIP modification terms

'

'

'

'

'

'

'

'

'

'

'

'Effective June 4, 2013, upon the approval of the Company's stockholders, the Company replaced the Amended and Restated 1998 Long-Term Incentive Plan (the "1998 LTIP") and the Amended and Restated Outside Directors Stock and Incentive Compensation Plan (the "ODSICP") with the 2013 Long-Term Incentive Plan (the "2013 LTIP"), a new combined plan covering all of the Company's employees and non-employee directors. The 2013 LTIP provides for 3.6 million shares available for grant at a rate of 1.00 share for each stock option or appreciation rights award granted and 2.09 shares for each full-value award granted. No shares remain available for new awards to be granted under the 1998 LTIP or the ODSICP.

'

'

'

Shares authorized to issue to officers and employees

'

'

'

'

'

'

'

'

'

'

3,600,000

3,600,000

'

'

'

Shares awarded per stock option grant

'

'

'

'

'

'

'

'

'

'

1

'

'

'

'

Shares awarded per full-value grant

'

'

'

'

'

'

'

'

'

'

2.09

'

'

'

'

Options granted in period

'

'

'

'

'

'

'

'

'

'

'

712,950

'

735,200

'

Vesting period

'

'

'

'

'3 years

'3 years

'

'3 years

'3 years

'

'

'

'

'

'6 months

Expiration period

'

'

'

'

'10 years

'10 years

'

'

'

'

'

'

'

'

'

Other stock based awards granted in period

'

'

'

'

'

'

'

'

236,000

307,000

'

366,271

23,912

410,000

'

Performance shares vesting parameters

'

'

'

'

'

'

'

'

'In addition to requiring continuing service of the employee, the percentage of these restricted stock units that are earned at the end of the performance period is determined based on the Company's three-year annualized total shareholder return relative to a peer group, Standard and Poor's Global Industry Classification Standard's Sub-industry: Health Care Facilities with over $500.0 million in revenues or its equivalent. The number of shares payable at the end of the three-year performance period ranges from 0% to 100% of the targeted units, with any portion of the award that exceeds 100% up to 200% of the targeted units settled in cash equal to the fair market value on the date certification of the level of performance is achieved.

'

'

'

'

'

'

Total intrinsic value of stock options exercised

'

'

$9.50

$8.70

'

'

'

'

'

'

'

'

'

'

'

Amount received in cash from stock option exercises

11.1

4.6

18.3

28.2

'

'

'

'

'

'

'

'

'

'

'

Actual tax benefit realized for the tax deductions from stock option exercises

'

'

1.2

0.1

'

'

'

'

'

'

'

'

'

'

'

Unrecognized compensation cost related to stock options

'

'

'

'

14

'

14

'

'

'

'

'

'

'

'

Unrecognized compensation cost related to other stock-based awards

'

'

'

'

'

'

'

29.9

'

'

'

'

'

'

'

Total estimated unrecognized compensation costs

$43.90

'

$43.90

'

'

'

'

'

'

'

'

'

'

'

'

Expected weighted average period for recognition of unrecognized compensation cost (in years)

'

'

'1 year 9 months 18 days

'

'

'

'1 year 4 months 24 days

'1 year 10 months 24 days

'

'

'

'

'

'

'

StockBased_Compensation_Schedu

Stock-Based Compensation (Schedule Of Estimates Of Weighted-Average Fair Value Per Share Of Stock Options Granted) (Details) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Stock-Based Compensation [Abstract]	'	'
Expected volatility	29.00%	31.00%
Risk free interest rate (range), minimum	0.05%	0.05%
Risk free interest rate (range), maximum	2.71%	1.95%
Average expected term (years)	'5 years 4 months 24 days	'5 years 3 months 18 days
Fair value per share of stock options granted	$13.95	$11.97

StockBased_Compensation_Schedu1

Stock-Based Compensation (Schedule Of Total Stock-Based Compensation Expense And Total Recognized Tax Benefits) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Stock-Based Compensation [Line Items]	'	'	'	'
Total stock-based compensation expense	$6.90	$6.30	$13.80	$13.10
Total stock-based compensation expense related to equity awards only	6.4	6.3	13.1	13.1
Stock-based compensation expense related to cash portion of equity awards	0.5	'	0.7	'
Tax benefit on stock-based compensation expense	2.7	2.5	5.5	5.3
Parent Issuer [Member]	'	'	'	'
Stock-Based Compensation [Line Items]	'	'	'	'
Total stock-based compensation expense related to equity awards only	6.4	6.3	13.1	13.1
Restricted Stock Units (RSUs) [Member]	'	'	'	'
Stock-Based Compensation [Line Items]	'	'	'	'
Total stock-based compensation expense	4.2	4.2	8.5	8.2
Stock Options [Member]	'	'	'	'
Stock-Based Compensation [Line Items]	'	'	'	'
Total stock-based compensation expense	$2.20	$2.10	$4.60	$4.90

Commitments_And_Contingencies_

Commitments And Contingencies (Narrative) (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Commitments And Contingencies [Abstract]	'	'
Minimum net proceeds to seller	$15	'
Fair value of potential obligation	18	'
Maximum advance payment committed to physicians	27.5	'
Physician minimum revenue guarantee liability	10.5	'
Uncompleted project costs included in construction in progress	60.1	58.7
Estimated cost to complete and equip construction in progress	$72.80	'

Earnings_Per_Share_Computation

Earnings Per Share (Computation Of Basic And Diluted Earnings (Loss) Per Share) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Income from continuing operations	$41.80	$27.20	$79.50	$60.20
Less: Net income attributable to noncontrolling interests	-2.7	-0.1	-3.3	-0.8
Income from continuing operations attributable to LifePoint Hospitals, Inc. stockholders	39.1	27.1	76.2	59.4
Income from discontinued operations, net of income taxes	'	0.3	'	0.4
Net income attributable to LifePoint Hospitals, Inc.	$39.10	$27.40	$76.20	$59.80
Weighted average shares outstanding - basic	44.5	46.5	45.2	46.2
Effect of dilutive securities: stock options and other stock-based awards	1.7	1.2	1.6	1.3
Effect of dilutive securities: convertible debt instruments	0.3	'	0.5	'
Weighted average shares outstanding - diluted	46.5	47.7	47.3	47.5
Continuing operations	$0.88	$0.58	$1.69	$1.29
Discontinued operations	'	$0.01	'	$0.01
Net income	$0.88	$0.59	$1.69	$1.30
Continuing operations	$0.84	$0.57	$1.61	$1.25
Discontinued operations	'	'	'	$0.01
Net income	$0.84	$0.57	$1.61	$1.26

Guarantor_And_NonGuarantor_Sup2

Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Statements Of Operations) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Revenues before provision for doubtful accounts	$1,246.20	$1,075.70	$2,429	$2,175.90
Provision for doubtful accounts	199.2	180.8	374.8	349.9
Revenues	1,047	894.9	2,054.20	1,826
Salaries and benefits	488.5	422.1	963.3	855.3
Supplies	162.5	144.1	319.5	288.8
Other operating expenses	258.3	222.9	501.8	444.4
Other income	-21	-11	-34.9	-16.7
Depreciation and amortization	60.9	55.9	122	111.7
Interest expense, net	31.3	22.6	65.2	46.5
Gain on settlement of pre-acquisition contingent obligation	'	-5.6	'	-5.6
Debt transaction costs	'	'	'	4.4
Operating expenses, total	980.5	851	1,936.90	1,728.80
Income from continuing operations before income taxes	66.5	43.9	117.3	97.2
(Benefit) provision for income taxes	24.7	16.7	37.8	37
Income from continuing operations	41.8	27.2	79.5	60.2
Income from discontinued operations, net of income taxes	'	0.3	'	0.4
Net income	41.8	27.5	79.5	60.6
Less: Net income attributable to noncontrolling interests	-2.7	-0.1	-3.3	-0.8
Net income attributable to LifePoint Hospitals, Inc.	39.1	27.4	76.2	59.8
Parent Issuer [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Salaries and benefits	6.9	6.3	13.8	13.1
Other operating expenses	'	0.1	'	0.5
Equity in earnings of affiliates	-57.6	-38	-113.9	-82.9
Interest expense, net	11.8	3.3	26.1	8.1
Debt transaction costs	'	'	'	4.4
Operating expenses, total	-38.9	-28.3	-74	-56.8
Income from continuing operations before income taxes	38.9	28.3	74	56.8
(Benefit) provision for income taxes	-0.2	0.9	-2.2	-3
Income from continuing operations	'	27.4	'	59.8
Net income	39.1	27.4	76.2	59.8
Net income attributable to LifePoint Hospitals, Inc.	39.1	27.4	76.2	59.8
Guarantors [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Revenues before provision for doubtful accounts	861.8	815.6	1,699.80	1,658.40
Provision for doubtful accounts	140.4	141.5	268.7	275.7
Revenues	721.4	674.1	1,431.10	1,382.70
Salaries and benefits	323.5	312.1	648	631.8
Supplies	104.4	102.3	207.1	202.9
Other operating expenses	187.2	171.5	367.9	345.7
Other income	-15.2	-9.9	-28.8	-15.6
Depreciation and amortization	46.1	43.4	91.4	87
Interest expense, net	17.7	17.1	34.7	34
Management (income) fees	-4.9	-3.2	-10	-6.5
Operating expenses, total	658.8	633.3	1,310.30	1,279.30
Income from continuing operations before income taxes	62.6	40.8	120.8	103.4
(Benefit) provision for income taxes	24.9	15.8	40	40
Income from continuing operations	'	25	'	63.4
Income from discontinued operations, net of income taxes	'	0.3	'	0.4
Net income	37.7	25.3	80.8	63.8
Less: Net income attributable to noncontrolling interests	-0.2	-0.3	-0.4	-0.3
Net income attributable to LifePoint Hospitals, Inc.	37.5	25	80.4	63.5
Non-Guarantors [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Revenues before provision for doubtful accounts	384.4	260.1	729.2	517.5
Provision for doubtful accounts	58.8	39.3	106.1	74.2
Revenues	325.6	220.8	623.1	443.3
Salaries and benefits	158.1	103.7	301.5	210.4
Supplies	58.1	41.8	112.4	85.9
Other operating expenses	71.1	51.3	133.9	98.2
Other income	-5.8	-1.1	-6.1	-1.1
Depreciation and amortization	14.8	12.5	30.6	24.7
Interest expense, net	1.8	2.2	4.4	4.4
Gain on settlement of pre-acquisition contingent obligation	'	-5.6	'	-5.6
Management (income) fees	4.9	3.2	10	6.5
Operating expenses, total	303	208	586.7	423.4
Income from continuing operations before income taxes	22.6	12.8	36.4	19.9
Income from continuing operations	'	12.8	'	19.9
Net income	22.6	12.8	36.4	19.9
Less: Net income attributable to noncontrolling interests	-2.5	0.2	-2.9	-0.5
Net income attributable to LifePoint Hospitals, Inc.	20.1	13	33.5	19.4
Eliminations [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Equity in earnings of affiliates	57.6	38	113.9	82.9
Operating expenses, total	57.6	38	113.9	82.9
Income from continuing operations before income taxes	-57.6	-38	-113.9	-82.9
Income from continuing operations	'	-38	'	-82.9
Net income	-57.6	-38	-113.9	-82.9
Net income attributable to LifePoint Hospitals, Inc.	($57.60)	($38)	($113.90)	($82.90)

Guarantor_And_NonGuarantor_Sup3

Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Balance Sheets) (Details) (USD $)	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'	'	'
Cash and cash equivalents	$342	$532.30	$637.90	$175	$160.40	$85
Accounts receivable, net	646.4	'	595.7	'	'	'
Inventories	106.9	'	102	'	'	'
Prepaid expenses	38.7	'	38	'	'	'
Deferred tax assets	130.1	'	147.7	'	'	'
Other current assets	106.5	'	72.9	'	'	'
Total current assets	1,370.60	'	1,594.20	'	'	'
Land	129.4	'	112.3	'	'	'
Buildings and improvements	2,065.70	'	2,019.60	'	'	'
Equipment	1,525.80	'	1,469.90	'	'	'
Construction in progress (estimated cost to complete and equip after June 30, 2014 is $72.8)	60.1	'	58.7	'	'	'
Property and equipment, gross	3,781	'	3,660.50	'	'	'
Accumulated depreciation	-1,563.60	'	-1,463.30	'	'	'
Property and equipment, net	2,217.40	'	2,197.20	'	'	'
Deferred loan costs, net	33.5	'	31.1	'	'	'
Intangible assets, net	71.4	'	72.6	'	'	'
Other	38.5	'	40.7	'	'	'
Goodwill	1,630.10	'	1,651	'	'	'
Total assets	5,361.50	'	5,586.80	'	'	'
Accounts payable	148.1	'	135.9	'	'	'
Accrued salaries	146.6	'	139.6	'	'	'
Other current liabilities	185.4	'	197.2	'	'	'
Current maturities of long-term debt	12.9	'	583	'	'	'
Total current liabilities	493	'	1,055.70	'	'	'
Long-term debt	2,202.50	'	1,793.80	'	'	'
Deferred income tax liabilities	203.8	'	233.1	'	'	'
Long-term portion of reserves for self-insurance claims	133.9	'	139.8	'	'	'
Other long-term liabilities	56.3	'	55.4	'	'	'
Long-term income tax liability	18.9	'	16.6	'	'	'
Total liabilities	3,108.40	'	3,294.40	'	'	'
Redeemable noncontrolling interests	84.7	'	59.8	'	'	'
Total LifePoint Hospitals, Inc. stockholders' equity	2,148.30	'	2,210.10	'	'	'
Noncontrolling interests	20.1	'	22.5	'	'	'
Total equity	2,168.40	'	2,232.60	'	'	'
Total liabilities and equity	5,361.50	'	5,586.80	'	'	'
Parent Issuer [Member]	'	'	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'	'	'
Prepaid expenses	0.3	'	0.1	'	'	'
Deferred tax assets	130.1	'	147.7	'	'	'
Other current assets	16.8	'	'	'	'	'
Total current assets	147.2	'	147.8	'	'	'
Deferred loan costs, net	33.5	'	31.1	'	'	'
Investments in subsidiaries	1,959.40	'	1,853.10	'	'	'
Due from susidiaries	2,399.80	'	2,760.40	'	'	'
Other	4.7	'	3.4	'	'	'
Total assets	4,544.60	'	4,795.80	'	'	'
Other current liabilities	12.9	'	14.8	'	'	'
Current maturities of long-term debt	11.3	'	581.4	'	'	'
Total current liabilities	24.2	'	596.2	'	'	'
Long-term debt	2,149.40	'	1,739.80	'	'	'
Deferred income tax liabilities	203.8	'	233.1	'	'	'
Long-term income tax liability	18.9	'	16.6	'	'	'
Total liabilities	2,396.30	'	2,585.70	'	'	'
Total LifePoint Hospitals, Inc. stockholders' equity	2,148.30	'	2,210.10	'	'	'
Total equity	2,148.30	'	2,210.10	'	'	'
Total liabilities and equity	4,544.60	'	4,795.80	'	'	'
Guarantors [Member]	'	'	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'	'	'
Cash and cash equivalents	234.9	441.8	558.3	105.2	90	25
Accounts receivable, net	472	'	444.3	'	'	'
Inventories	73	'	73.4	'	'	'
Prepaid expenses	29.1	'	30.6	'	'	'
Other current assets	50.9	'	53	'	'	'
Total current assets	859.9	'	1,159.60	'	'	'
Land	73.8	'	76	'	'	'
Buildings and improvements	1,578.20	'	1,570.10	'	'	'
Equipment	1,271.70	'	1,256.40	'	'	'
Construction in progress (estimated cost to complete and equip after June 30, 2014 is $72.8)	41.3	'	45.6	'	'	'
Property and equipment, gross	2,965	'	2,948.10	'	'	'
Accumulated depreciation	-1,380.40	'	-1,309	'	'	'
Property and equipment, net	1,584.60	'	1,639.10	'	'	'
Intangible assets, net	37.3	'	40.3	'	'	'
Other	19.3	'	22.4	'	'	'
Goodwill	1,435.40	'	1,435.10	'	'	'
Total assets	3,936.50	'	4,296.50	'	'	'
Accounts payable	101	'	99.1	'	'	'
Accrued salaries	102.6	'	102.1	'	'	'
Other current liabilities	122	'	146.4	'	'	'
Current maturities of long-term debt	0.6	'	0.7	'	'	'
Total current liabilities	326.2	'	348.3	'	'	'
Long-term debt	49.5	'	50	'	'	'
Intercompany	1,914.40	'	2,324.80	'	'	'
Long-term portion of reserves for self-insurance claims	104.8	'	113.5	'	'	'
Other long-term liabilities	20.6	'	20.2	'	'	'
Total liabilities	2,415.50	'	2,856.80	'	'	'
Total LifePoint Hospitals, Inc. stockholders' equity	1,519.70	'	1,438.20	'	'	'
Noncontrolling interests	1.3	'	1.5	'	'	'
Total equity	1,521	'	1,439.70	'	'	'
Total liabilities and equity	3,936.50	'	4,296.50	'	'	'
Non-Guarantors [Member]	'	'	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'	'	'
Cash and cash equivalents	107.1	90.5	79.6	69.8	70.4	60
Accounts receivable, net	174.4	'	151.4	'	'	'
Inventories	33.9	'	28.6	'	'	'
Prepaid expenses	9.3	'	7.3	'	'	'
Other current assets	38.8	'	19.9	'	'	'
Total current assets	363.5	'	286.8	'	'	'
Land	55.6	'	36.3	'	'	'
Buildings and improvements	487.5	'	449.5	'	'	'
Equipment	254.1	'	213.5	'	'	'
Construction in progress (estimated cost to complete and equip after June 30, 2014 is $72.8)	18.8	'	13.1	'	'	'
Property and equipment, gross	816	'	712.4	'	'	'
Accumulated depreciation	-183.2	'	-154.3	'	'	'
Property and equipment, net	632.8	'	558.1	'	'	'
Intangible assets, net	34.1	'	32.3	'	'	'
Other	14.5	'	14.9	'	'	'
Goodwill	194.7	'	215.9	'	'	'
Total assets	1,239.60	'	1,108	'	'	'
Accounts payable	47.1	'	36.8	'	'	'
Accrued salaries	44	'	37.5	'	'	'
Other current liabilities	50.5	'	36	'	'	'
Current maturities of long-term debt	1	'	0.9	'	'	'
Total current liabilities	142.6	'	111.2	'	'	'
Long-term debt	3.6	'	4	'	'	'
Intercompany	485.4	'	435.6	'	'	'
Long-term portion of reserves for self-insurance claims	29.1	'	26.3	'	'	'
Other long-term liabilities	35.7	'	35.2	'	'	'
Total liabilities	696.4	'	612.3	'	'	'
Redeemable noncontrolling interests	84.7	'	59.8	'	'	'
Total LifePoint Hospitals, Inc. stockholders' equity	439.7	'	414.9	'	'	'
Noncontrolling interests	18.8	'	21	'	'	'
Total equity	458.5	'	435.9	'	'	'
Total liabilities and equity	1,239.60	'	1,108	'	'	'
Eliminations [Member]	'	'	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'	'	'
Investments in subsidiaries	-1,959.40	'	-1,853.10	'	'	'
Due from susidiaries	-2,399.80	'	-2,760.40	'	'	'
Total assets	-4,359.20	'	-4,613.50	'	'	'
Intercompany	-2,399.80	'	-2,760.40	'	'	'
Total liabilities	-2,399.80	'	-2,760.40	'	'	'
Total LifePoint Hospitals, Inc. stockholders' equity	-1,959.40	'	-1,853.10	'	'	'
Total equity	-1,959.40	'	-1,853.10	'	'	'
Total liabilities and equity	($4,359.20)	'	($4,613.50)	'	'	'

Guarantor_And_NonGuarantor_Sup4

Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Statements Of Cash Flows) (Details) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Net income	$41.80	$27.50	$79.50	$60.60
Income from discontinued operations, net of income taxes	'	-0.3	'	-0.4
Stock-based compensation	6.4	6.3	13.1	13.1
Depreciation and amortization	60.9	55.9	122	111.7
Amortization of physician minimum revenue guarantees	3.8	4.5	7.7	9
Amortization of debt discounts, premium and deferred loan costs	4.3	6	11.6	13.1
Gain on settlement of pre-acquisition contingent obligation	'	-5.6	'	-5.6
Debt transaction costs	'	'	'	4.4
Deferred income taxes (benefit)	36.5	-36.6	-5.1	-43.7
Reserve for self-insurance claims, net of payments	-1.4	2.1	4.7	6.7
Accounts receivable	22.2	10.9	-28.3	-18.6
Inventories and other current assets	-2.7	10.9	20.4	4.8
Accounts payable and accrued expenses	-31.3	-15.8	-31.6	-26
Income taxes payable /receivable	-71.8	-7.5	-19.3	19.5
Other	-0.7	-0.8	1.9	0.7
Net cash provided by operating activities-continuing operations	68	57.5	176.6	149.3
Net cash used in operating activities-discontinued operations	'	-0.6	'	-0.2
Net cash provided by operating activities	68	56.9	176.6	149.1
Purchases of property and equipment	-31.2	-37.3	-53.7	-75.8
Acquisitions, net of cash acquired	-27.2	-4.9	-87.8	-6.2
Other	0.1	1.2	-0.4	1.4
Net cash used in investing activities	-58.3	-41	-141.9	-80.6
Proceeds from borrowings	412	'	412	323
Payments of borrowings	-579.8	-3.6	-579.8	-317.2
Repurchases of common stock	-36.1	-0.1	-171.9	-7.2
Payment of debt financing costs	-5.5	-0.1	-5.9	-1
Proceeds from exercise of stock options	11.1	4.6	18.3	28.2
Other	-1.7	-2.1	-3.3	-4.3
Net cash (used in) provided by financing activities	-200	-1.3	-330.6	21.5
Change in cash and cash equivalents	-190.3	14.6	-295.9	90
Cash and cash equivalents at beginning of period	532.3	160.4	637.9	85
Cash and cash equivalents at end of period	342	175	342	175
Parent Issuer [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Net income	39.1	27.4	76.2	59.8
Equity in earnings of affiliates	-57.6	-38	-113.9	-82.9
Stock-based compensation	6.4	6.3	13.1	13.1
Amortization of debt discounts, premium and deferred loan costs	4.3	6	11.6	13.1
Debt transaction costs	'	'	'	4.4
Deferred income taxes (benefit)	36.5	-36.6	-5.1	-43.7
Inventories and other current assets	-0.3	-0.1	-0.2	'
Accounts payable and accrued expenses	-21	-11.8	0.7	-2.4
Income taxes payable /receivable	-71.8	-7.5	-19.3	19.5
Other	'	-0.1	-0.1	'
Net cash provided by operating activities-continuing operations	'	-54.4	'	-19.1
Net cash provided by operating activities	-64.4	-54.4	-37	-19.1
Other	-0.4	'	-1.2	-0.2
Net cash used in investing activities	-0.4	'	-1.2	-0.2
Proceeds from borrowings	412	'	412	323
Payments of borrowings	-579.8	-3.6	-579.8	-317.2
Repurchases of common stock	-36.1	-0.1	-171.9	-7.2
Payment of debt financing costs	-5.5	-0.1	-5.9	-1
Proceeds from exercise of stock options	11.1	4.6	18.3	28.2
Change in intercompany balances with affiliates, net	263.2	53.8	365.6	-6.3
Other	-0.1	-0.2	-0.1	-0.2
Net cash (used in) provided by financing activities	64.8	54.4	38.2	19.3
Guarantors [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Net income	37.7	25.3	80.8	63.8
Income from discontinued operations, net of income taxes	'	-0.3	'	-0.4
Depreciation and amortization	46.1	43.4	91.4	87
Amortization of physician minimum revenue guarantees	3.3	4.2	6.9	8.2
Reserve for self-insurance claims, net of payments	-1.4	0.2	1.9	0.6
Accounts receivable	2.9	1	-29.3	-23.6
Inventories and other current assets	-5.2	12.2	18.6	6.4
Accounts payable and accrued expenses	-16.6	-8.1	-45.1	-31.8
Other	0.2	-0.5	1.5	0.4
Net cash provided by operating activities-continuing operations	'	77.4	'	110.6
Net cash used in operating activities-discontinued operations	'	-0.6	'	-0.2
Net cash provided by operating activities	67	76.8	126.7	110.4
Purchases of property and equipment	-21.6	-28.5	-37.3	-58.3
Acquisitions, net of cash acquired	'	-4.9	-2.7	-6.2
Other	1	0.2	0.4	0.6
Net cash used in investing activities	-20.6	-33.2	-39.6	-63.9
Change in intercompany balances with affiliates, net	-253.2	-28.5	-410.4	33.8
Other	-0.1	0.1	-0.1	-0.1
Net cash (used in) provided by financing activities	-253.3	-28.4	-410.5	33.7
Change in cash and cash equivalents	-206.9	15.2	-323.4	80.2
Cash and cash equivalents at beginning of period	441.8	90	558.3	25
Cash and cash equivalents at end of period	234.9	105.2	234.9	105.2
Non-Guarantors [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Net income	22.6	12.8	36.4	19.9
Depreciation and amortization	14.8	12.5	30.6	24.7
Amortization of physician minimum revenue guarantees	0.5	0.3	0.8	0.8
Gain on settlement of pre-acquisition contingent obligation	'	-5.6	'	-5.6
Reserve for self-insurance claims, net of payments	'	1.9	2.8	6.1
Accounts receivable	19.3	9.9	1	5
Inventories and other current assets	2.8	-1.2	2	-1.6
Accounts payable and accrued expenses	6.3	4.1	12.8	8.2
Other	-0.9	-0.2	0.5	0.3
Net cash provided by operating activities-continuing operations	'	34.5	'	57.8
Net cash provided by operating activities	65.4	34.5	86.9	57.8
Purchases of property and equipment	-9.6	-8.8	-16.4	-17.5
Acquisitions, net of cash acquired	-27.2	'	-85.1	'
Other	-0.5	1	0.4	1
Net cash used in investing activities	-37.3	-7.8	-101.1	-16.5
Change in intercompany balances with affiliates, net	-10	-25.3	44.8	-27.5
Other	-1.5	-2	-3.1	-4
Net cash (used in) provided by financing activities	-11.5	-27.3	41.7	-31.5
Change in cash and cash equivalents	16.6	-0.6	27.5	9.8
Cash and cash equivalents at beginning of period	90.5	70.4	79.6	60
Cash and cash equivalents at end of period	107.1	69.8	107.1	69.8
Eliminations [Member]	'	'	'	'
Guarantor And Non-Guarantor Supplementary Information [Line Items]	'	'	'	'
Net income	-57.6	-38	-113.9	-82.9
Equity in earnings of affiliates	$57.60	$38	$113.90	$82.90